TWI632177B - Liquid crystal alignment film, liquid crystal display element and manufacturing method of the same - Google Patents

Liquid crystal alignment film, liquid crystal display element and manufacturing method of the same Download PDF

Info

Publication number
TWI632177B
TWI632177B TW104137827A TW104137827A TWI632177B TW I632177 B TWI632177 B TW I632177B TW 104137827 A TW104137827 A TW 104137827A TW 104137827 A TW104137827 A TW 104137827A TW I632177 B TWI632177 B TW I632177B
Authority
TW
Taiwan
Prior art keywords
group
liquid crystal
formula
crystal alignment
alignment film
Prior art date
Application number
TW104137827A
Other languages
Chinese (zh)
Other versions
TW201718708A (en
Inventor
蔡宗沛
黃菀婷
邱信融
Original Assignee
奇美實業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇美實業股份有限公司 filed Critical 奇美實業股份有限公司
Priority to TW104137827A priority Critical patent/TWI632177B/en
Priority to CN201610976074.8A priority patent/CN106978195B/en
Publication of TW201718708A publication Critical patent/TW201718708A/en
Application granted granted Critical
Publication of TWI632177B publication Critical patent/TWI632177B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F122/00Homopolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F122/36Amides or imides
    • C08F122/40Imides, e.g. cyclic imides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F22/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F22/36Amides or imides
    • C08F22/40Imides, e.g. cyclic imides
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nonlinear Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)

Abstract

本發明提供一種液晶配向膜、液晶顯示元件以及其製造方法。所述液晶配向膜包括由式(1)表示的架橋結構:式(1) 式(1)中,T表示脂肪族系、脂環族系或芳香族系的結構;Q表示含有光反應性基的有機基團;k表示1以上的整數。The invention provides a liquid crystal alignment film, a liquid crystal display element and a manufacturing method thereof. The liquid crystal alignment film includes a bridge structure represented by formula (1): Formula (1) In Formula (1), T represents an aliphatic, alicyclic or aromatic structure; Q represents an organic group containing a photoreactive group; and k represents an integer of 1 or more.

Description

液晶配向膜、液晶顯示元件以及其製造方法Liquid crystal alignment film, liquid crystal display element and manufacturing method thereof

本發明是關於一種液晶配向膜、液晶顯示元件以及其製造方法,特別是關於一種可形成聚合性化合物殘留少、並且長期信賴性佳的液晶顯示元件的液晶配向膜、具有上述液晶配向膜的液晶顯示元件,以及所述液晶顯示元件的製造方法。The present invention relates to a liquid crystal alignment film, a liquid crystal display element, and a method for manufacturing the same, and more particularly, to a liquid crystal alignment film capable of forming a liquid crystal display element with little residual polymerizable compound and excellent long-term reliability, and a liquid crystal having the liquid crystal alignment film A display element and a method for manufacturing the liquid crystal display element.

隨著液晶顯示器朝向大尺寸的顯示規格發展,為了克服大尺寸顯示下的視角問題,液晶顯示面板的廣視角技術也必須不停地進步與突破。多域垂直配向型(Multi-domain Vertical Alignment,MVA)液晶顯示面板即為常見的一種廣視角技術。多域垂直配向型的液晶顯示面板是在液晶面板中形成突起物,此突起物可限定液晶分子傾倒的方向,藉此可達到廣視角的顯示效果。然而,多域垂直配向型的液晶顯示面板卻無法避免源自於突起物的透光率及對比度不足以及液晶分子應答速度緩慢的問題。With the development of liquid crystal displays toward large-sized display specifications, in order to overcome the problem of viewing angles in large-sized displays, the wide-viewing angle technology of liquid crystal display panels must also continue to improve and breakthrough. Multi-domain Vertical Alignment (MVA) liquid crystal display panel is a common wide viewing angle technology. The multi-domain vertical alignment type liquid crystal display panel is formed with protrusions in the liquid crystal panel, and the protrusions can limit the direction in which the liquid crystal molecules are tilted, thereby achieving a wide viewing angle display effect. However, the multi-domain vertical alignment type liquid crystal display panel cannot avoid problems caused by insufficient transmittance and contrast of the protrusions and slow response speed of the liquid crystal molecules.

近年來,為了解決上述問題,目前發展出一種聚合物穩定配向型(Polymer Sustained Alignment,PSA)的技術。此技術乃是在由具有圖案狀導電膜的基板與不具有圖案狀導電膜的基板所組成的一對基板的間隙中、或者由兩枚具有圖案狀導電膜的基板所組成的一對基板的間隙中,挾持含有聚合性化合物的液晶組成物,於導電膜間施加電壓的狀態下,對液晶組成物照射紫外光而使聚合性化合物進行聚合,藉此展現出預傾角特性,並控制液晶配向方向。此技術可使導電膜形成特定的構成,而達到擴大視角及使液晶分子應答高速化的效果,從而解決了多域垂直配向型的液晶顯示面板無法避免的透光率及對比度不足的問題。In recent years, in order to solve the above problems, a polymer stabilized alignment (Polymer Sustained Alignment, PSA) technology has been developed. This technology uses a gap between a pair of substrates composed of a substrate with a patterned conductive film and a substrate without a patterned conductive film, or a pair of substrates composed of two substrates with a patterned conductive film. In the gap, a liquid crystal composition containing a polymerizable compound is held, and the liquid crystal composition is irradiated with ultraviolet light to polymerize the polymerizable compound while a voltage is applied between the conductive films, thereby exhibiting a pretilt angle characteristic and controlling the liquid crystal alignment direction. This technology enables the conductive film to form a specific structure, thereby achieving the effects of widening the viewing angle and speeding up the response of liquid crystal molecules, thereby solving the problems of unavoidable light transmittance and contrast of the multi-domain vertical alignment type liquid crystal display panel.

然而,為了聚合前述聚合性化合物,必須照射例如100,000 J/m2 這樣大量的紫外線,因此,除了產生液晶分子分解的問題,更產生即使照射紫外線仍無法聚合的未反應化合物殘留在液晶層中的問題。殘留的未反應化合物在液晶層中互相結合而導致面板的長期信賴性不佳,從而無法達到實用程度。However, in order to polymerize the aforementioned polymerizable compound, a large amount of ultraviolet rays such as 100,000 J / m 2 must be irradiated. Therefore, in addition to the problem of decomposition of the liquid crystal molecules, unreacted compounds that cannot be polymerized even when irradiated with ultraviolet rays remain in the liquid crystal layer. problem. The remaining unreacted compounds are bonded to each other in the liquid crystal layer, which results in poor long-term reliability of the panel, and thus cannot reach a practical level.

因此,如何改善上述問題,實為目前本領域技術人員積極研究的目標之一。Therefore, how to improve the above problems is actually one of the goals actively studied by those skilled in the art.

有鑑於此,本發明提供一種可形成聚合性化合物殘留少、並且長期信賴性佳的液晶顯示元件的液晶配向膜、具有上述液晶配向膜的液晶顯示元件,以及所述液晶顯示元件的製造方法。In view of this, the present invention provides a liquid crystal alignment film capable of forming a liquid crystal display element with little residual polymerizable compound and excellent long-term reliability, a liquid crystal display element including the liquid crystal alignment film, and a method for manufacturing the liquid crystal display element.

本發明提供一種液晶配向膜,包括由式(1)表示的架橋結構:式(1) 式(1)中,T表示脂肪族系、脂環族系或芳香族系的結構;Q表示含有光反應性基的有機基團;k表示1以上的整數。The present invention provides a liquid crystal alignment film, including a bridge structure represented by formula (1): Formula (1) In Formula (1), T represents an aliphatic, alicyclic or aromatic structure; Q represents an organic group containing a photoreactive group; and k represents an integer of 1 or more.

在本發明的一實施例中,上述的光反應性基包括乙烯基、(甲基)丙烯酸基、蒽基(anthracenyl group)、桂皮酸基(cinnamoyl group)、查耳酮基(chalconyl group)、香豆基(coumarin group)、馬來醯亞胺基(maleimide group)或二苯乙烯基(stilbenyl group)中的至少一者。In an embodiment of the present invention, the photoreactive group includes a vinyl group, a (meth) acrylic group, an anthracenyl group, a cinnamoyl group, a chalconyl group, At least one of a coumarin group, a maleimide group, or a stilbenyl group.

在本發明的一實施例中,上述的架橋結構由具有馬來醯胺酸基的化合物(A)經自由基聚合反應而得,所述具有馬來醯胺酸基的化合物(A)於一分子中具有2個或2個以上可聚合性的馬來醯胺酸基。In an embodiment of the present invention, the above-mentioned bridging structure is obtained from a compound (A) having a maleic acid group through a radical polymerization reaction, and the compound (A) having a maleic acid group is It has two or more polymerizable maleic acid amino groups in the molecule.

在本發明的一實施例中,上述的自由基聚合反應發生在所述具有馬來醯胺酸基的化合物(A)經脫水閉環反應後生成的雙鍵上。In an embodiment of the present invention, the above-mentioned free radical polymerization reaction occurs on a double bond formed after the compound (A) having a maleic acid amino group undergoes a dehydration ring-closing reaction.

在本發明的一實施例中,上述的具有馬來醯胺酸基的化合物(A)由馬來酸酐衍生物(a1)及二胺組份(a2)反應而得。In one embodiment of the present invention, the compound (A) having a maleic acid amino group is obtained by reacting a maleic anhydride derivative (a1) and a diamine component (a2).

在本發明的一實施例中,上述的二胺組份(a2)包含由式(2)表示的二胺化合物(a2-1):式(2) 式(2)中,Ra 表示-CH2 -、-O-、-NH-、-N(CH3 )-、-CONH-、-NHCO-、-CH2 O-、-COO-、-OCO-、-CON(CH3 )-或-N(CH3 )CO-。Rb 表示碳數為1至20的未經取代或經氟原子取代的直鏈狀伸烷基,且所述伸烷基中任意的-CH2 -可經-CF2 -、-CH=CH-或下述的取代基取代,所述取代基包括:-O-、-COO-、-NHCO-、-NH-、碳環基或雜環基,其中,當兩個以上的-CH2 -經所述取代基取代時,所述取代基不相鄰接。Rc 表示-CH2 -、-O-、-NH-、-N(CH3 )-、-CONH-、-NHCO-、-CH2 O-、-COO-、-OCO-、-CON(CH3 )-、-N(CH3 )CO-、碳環基或雜環基。Rd 表示乙烯苯基、-CRe =CH2 、碳環基、雜環基、或由下述結構式表示的基團,Re 表示氫原子或可經氟原子取代之甲基: In an embodiment of the present invention, the diamine component (a2) includes a diamine compound (a2-1) represented by the formula (2): Formula (2) In formula (2), R a represents -CH 2- , -O-, -NH-, -N (CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -COO -, -OCO-, -CON (CH 3 )-or -N (CH 3 ) CO-. R b represents a carbon number of from 1 to 20 non-substituted or fluorine-substituted linear alkylene group, and in the alkylene arbitrary -CH 2 - may be -CF 2 -, - CH = CH -Or the following substituents, which include: -O-, -COO-, -NHCO-, -NH-, carbocyclyl or heterocyclic group, wherein when two or more -CH 2- When substituted with the substituent, the substituents are not adjacent. R c represents -CH 2- , -O-, -NH-, -N (CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -COO-, -OCO-, -CON (CH 3) -, - N (CH 3) CO-, carbocyclic group or heterocyclic group. R d represents a vinyl phenyl group, -CR e = CH 2 , a carbocyclic group, a heterocyclic group, or a group represented by the following structural formula, and R e represents a hydrogen atom or a methyl group which may be substituted by a fluorine atom: .

在本發明的一實施例中,上述的二胺組份(a2)更包含由式(3)表示的二胺化合物(a2-2):式(3) 式(3)中,R3 表示-O-、,或者;R4 表示含甾基團、碳數為2至30的伸烷基或由式(3-1)表示的有機基團:式(3-1) 式(3-1)中,R5 表示氫原子、氟原子或甲基;R6 、R7 或R8 各自獨立表示單鍵、-O-、或碳數為1至3的伸烷基;R9 表示,其中,R11 及R12 各自獨立表示氫原子、氟原子或甲基;R10 表示氫原子、氟原子、碳數為1至12的烷基、碳數為1至12的氟烷基、碳數為1至12的烷氧基、-OCH2 F、-OCHF2 或-OCF3 ;a表示1或2;b、c及d各自獨立表示0至4的整數;e、f及g各自獨立表示0至3的整數,且e+f+g≧1;h及i各自獨立表示1或2;當存在多個R5 、R6 、R7 、R8 、R9 、R10 、R11 或R12 的情況下,多個R5 、R6 、R7 、R8 、R9 、R10 、R11 或R12 各自為相同或不同。In an embodiment of the present invention, the diamine component (a2) further includes a diamine compound (a2-2) represented by the formula (3): Formula (3) In Formula (3), R 3 represents -O-, , , , ,or ; R 4 represents a steroid-containing group, an alkylene group having 2 to 30 carbon atoms, or an organic group represented by the formula (3-1): Formula (3-1) In formula (3-1), R 5 represents a hydrogen atom, a fluorine atom or a methyl group; R 6 , R 7 or R 8 each independently represents a single bond, -O-, , , , , Or an alkylene group having 1 to 3 carbon atoms; R 9 represents or Wherein R 11 and R 12 each independently represent a hydrogen atom, a fluorine atom or a methyl group; R 10 represents a hydrogen atom, a fluorine atom, an alkyl group having 1 to 12 carbon atoms, a fluoroalkyl group having 1 to 12 carbon atoms, Alkoxy, -OCH 2 F, -OCHF 2 or -OCF 3 having a carbon number of 1 to 12; a represents 1 or 2; b, c, and d each independently represent an integer of 0 to 4; e, f, and g each Independently represents an integer from 0 to 3, and e + f + g ≧ 1; h and i each independently represent 1 or 2; when there are multiple R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R In the case of 11 or R 12 , a plurality of R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 or R 12 are each the same or different.

在本發明的一實施例中,基於所述二胺組份(a2)為100莫耳,所述二胺化合物(a2-1)的使用量為5莫耳至70莫耳。In an embodiment of the present invention, based on the diamine component (a2) being 100 moles, the amount of the diamine compound (a2-1) used is 5 moles to 70 moles.

在本發明的一實施例中,基於所述二胺組份(a2)為100莫耳,所述二胺化合物(a2-2)的使用量為3莫耳至50莫耳。In an embodiment of the present invention, based on the diamine component (a2) being 100 moles, the amount of the diamine compound (a2-2) used is 3 moles to 50 moles.

本發明還提供一種液晶顯示元件,其包括如上述的液晶配向膜。The present invention also provides a liquid crystal display element including the liquid crystal alignment film as described above.

本發明更提供一種液晶顯示元件的製造方法,其至少包括以下步驟:分別於包含導電膜的一對基板上形成如上述的液晶配向膜。將形成有所述液晶配向膜的所述基板以所述液晶配向膜對向的方式配置。於所述基板之間注入液晶組成物而形成液晶胞。以及於所述導電膜間施加電壓,並於施加電壓狀態下用光照射所述液晶胞。The invention further provides a method for manufacturing a liquid crystal display element, which includes at least the following steps: forming a liquid crystal alignment film as described above on a pair of substrates including a conductive film, respectively. The substrate on which the liquid crystal alignment film is formed is arranged so that the liquid crystal alignment film faces each other. A liquid crystal composition is injected between the substrates to form a liquid crystal cell. And applying a voltage between the conductive films, and irradiating the liquid crystal cell with light in a state where the voltage is applied.

基於上述,本發明的液晶配向膜中包含特定的架橋結構,因此不會有液晶層中殘留未反應化合物的問題。進一步而言,本發明的液晶配向膜由於包含含有光反應性基的有機基團的架橋結構,而使液晶層中不殘留未反應化合物,並且面板的長期信賴性佳,因此適用於製造液晶配向膜及液晶顯示元件。Based on the above, the liquid crystal alignment film of the present invention includes a specific bridging structure, so there is no problem that unreacted compounds remain in the liquid crystal layer. Furthermore, the liquid crystal alignment film of the present invention contains a bridging structure of an organic group containing a photoreactive group, so that no unreacted compounds remain in the liquid crystal layer, and the long-term reliability of the panel is excellent, so it is suitable for manufacturing liquid crystal alignment. Film and liquid crystal display element.

為讓本發明的上述特徵和優點能更明顯易懂,下文特舉實施例,並作詳細說明如下。In order to make the above features and advantages of the present invention more comprehensible, embodiments are hereinafter given and described in detail as follows.

在此說明的是,以下是以(甲基)丙烯酸表示丙烯酸及/或甲基丙烯酸,並以(甲基)丙烯酸酯表示丙烯酸酯及/或甲基丙烯酸酯;同樣地,以(甲基)丙烯醯基表示丙烯醯基及/或甲基丙烯醯基。 液晶配向膜 Here, it is explained that acrylic acid and / or methacrylic acid are represented by (meth) acrylic acid, and acrylate and / or methacrylic acid ester are represented by (meth) acrylate; similarly, (meth) Acrylofluorenyl refers to acrylfluorenyl and / or methacrylfluorenyl. Liquid crystal alignment film

本發明提供一種液晶配向膜,其由液晶配向劑形成。所述液晶配向劑包括具有馬來醯胺酸基的化合物(A)以及溶劑(C)。此外,若需要,液晶配向劑可更包括聚合物(B)及添加劑(D)。The invention provides a liquid crystal alignment film formed of a liquid crystal alignment agent. The liquid crystal alignment agent includes a compound (A) having a maleic acid group and a solvent (C). In addition, if necessary, the liquid crystal alignment agent may further include a polymer (B) and an additive (D).

本發明的液晶配向膜包括由式(1)表示的架橋結構:式(1) 式(1)中,T表示脂肪族系、脂環族系或芳香族系的結構;Q表示含有光反應性基的有機基團;k表示1以上的整數。The liquid crystal alignment film of the present invention includes a bridge structure represented by formula (1): Formula (1) In Formula (1), T represents an aliphatic, alicyclic or aromatic structure; Q represents an organic group containing a photoreactive group; and k represents an integer of 1 or more.

上述含有光反應性基的有機基團為具有可藉由紫外線之照射引起光反應,形成共價鍵之官能基之有機基團,其構造只要是具有該能力則無限制。所述光反應性基包括乙烯基、(甲基)丙烯酸基、蒽基、桂皮酸基、查耳酮基、香豆基、馬來醯亞胺基、二苯乙烯基或上述基團的組合。所述光反應性基可直接鍵結於所述架橋結構上,亦可透過適當之鍵結基鍵結。The above-mentioned photoreactive group-containing organic group is an organic group having a functional group capable of causing a photoreaction by irradiation of ultraviolet rays to form a covalent bond, and its structure is not limited as long as it has this ability. The photoreactive group includes a vinyl group, a (meth) acrylic group, an anthryl group, a cinnamic acid group, a chalcone group, a coumaryl group, a maleimide group, a distyryl group, or a combination thereof. . The photoreactive group may be directly bonded to the bridging structure, or may be bonded through an appropriate bonding group.

所述光反應性基可列舉由下述式所表示的基團,但不限於此。 -Ra -Rb -Rc -Rd 式(1-1)Examples of the photoreactive group include, but are not limited to, the group represented by the following formula. -R a -R b -R c -R d Formula (1-1)

式(1-1)中,Ra 表示-CH2 -、-O-、-NH-、-N(CH3 )-、-CONH-、-NHCO-、-CH2 O-、-COO-、-OCO-、-CON(CH3 )-、或-N(CH3 )CO-。In formula (1-1), R a represents -CH 2- , -O-, -NH-, -N (CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -COO-, -OCO-, -CON (CH 3 )-, or -N (CH 3 ) CO-.

Rb 表示碳數為1至20的未經取代或經氟原子取代的直鏈狀伸烷基,且所述伸烷基中任意的-CH2 -可經-CF2 -、-CH=CH-、或下述的取代基取代,所述取代基包括:-O-、-COO-、-NHCO-、-NH-、碳環基或雜環基,其中,當兩個以上的-CH2 -經所述取代基取代時,所述取代基不相鄰接。R b represents an unsubstituted or fluorine-substituted linear alkylene group having a carbon number of 1 to 20, and any -CH 2 -in the alkylene group may be -CF 2- , -CH = CH -, Or the following substituents, which include: -O-, -COO-, -NHCO-, -NH-, carbocyclyl or heterocyclic group, wherein when two or more -CH 2 -When substituted with the substituent, the substituents are not adjacent.

Rc 表示-CH2 -、-O-、-NH-、-N(CH3 )-、-CONH-、-NHCO-、-CH2 O-、-COO-、-OCO-、-CON(CH3 )-、-N(CH3 )CO-、碳環基或雜環基。R c represents -CH 2- , -O-, -NH-, -N (CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -COO-, -OCO-, -CON (CH 3) -, - N (CH 3) CO-, carbocyclic group or heterocyclic group.

Rd 表示乙烯苯基、-CRe =CH2 、碳環基、雜環基、或由下述結構式表示的基團,Re 表示氫原子或可經氟原子取代之甲基。 R d represents a vinylphenyl group, -CR e = CH 2 , a carbocyclic group, a heterocyclic group, or a group represented by the following structural formula, and R e represents a hydrogen atom or a methyl group which may be substituted with a fluorine atom.

當液晶配向膜中的架橋結構不具有含有光反應性基的有機基團時,則由該液晶配向膜所製得之液晶顯示元件經紫外線照射後,液晶層仍易有聚合性化合物殘留的問題。When the bridging structure in the liquid crystal alignment film does not have an organic group containing a photoreactive group, after the liquid crystal display element prepared from the liquid crystal alignment film is irradiated with ultraviolet rays, the liquid crystal layer is still prone to the problem of polymerizable compounds remaining .

由式(1)表示的架橋結構由具有馬來醯胺酸基的化合物(A)經自由基聚合反應而得,所述具有馬來醯胺酸基的化合物(A)於一分子中具有2個或2個以上可聚合性的馬來醯胺酸基,並且其由馬來酸酐衍生物(a1)及二胺組份(a2)反應而得。The bridging structure represented by the formula (1) is obtained from a compound (A) having a maleic acid group through a radical polymerization reaction, and the compound (A) having a maleic acid group has 2 in one molecule. Two or more polymerizable maleic acid amino groups are obtained by reacting a maleic anhydride derivative (a1) and a diamine component (a2).

在下文中,將詳細說明具有馬來醯胺酸基的化合物(A)。具有馬來醯胺酸基的化合物( A Hereinafter, the compound (A) having a maleic acid group will be described in detail. Compounds with maleic acid ( A )

具有馬來醯胺酸基的化合物(A)於一分子中具有2個或2個以上可聚合性的馬來醯胺酸基,並且是由馬來酸酐衍生物(a1)及二胺組份(a2)反應而獲得。馬來酸酐衍生物( a1 The compound (A) having a maleic acid group has two or more polymerizable maleic acid groups in one molecule, and is composed of a maleic anhydride derivative (a1) and a diamine component. (A2) obtained by reaction. Maleic anhydride derivative ( a1 )

馬來酸酐衍生物(a1)的具體例可包括但不限於:馬來酸酐、2,3-二甲基馬來酸酐、2-甲基馬來酸酐、2,3-二乙基馬來酸酐、2-乙基馬來酸酐或上述化合物的組合。較佳為馬來酸酐、2-甲基馬來酸酐或2-乙基馬來酸酐,更佳為馬來酸酐或2-甲基馬來酸酐。馬來酸酐衍生物(a1)可以使用單獨一種或者組合多種來使用。二胺組份( a2 Specific examples of the maleic anhydride derivative (a1) may include, but are not limited to, maleic anhydride, 2,3-dimethylmaleic anhydride, 2-methylmaleic anhydride, and 2,3-diethylmaleic anhydride , 2-ethylmaleic anhydride, or a combination of the above. Maleic anhydride, 2-methylmaleic anhydride or 2-ethylmaleic anhydride is preferred, and maleic anhydride or 2-methylmaleic anhydride is more preferred. The maleic anhydride derivative (a1) can be used alone or in combination. Diamine component ( a2 )

二胺組份(a2)包括由式(2)表示的二胺化合物(a2-1)以及由式(3)表示的二胺化合物(a2-2)。此外,二胺組份(a2)亦可包括其他二胺化合物(a2-3)。二胺化合物( a2-1 The diamine component (a2) includes a diamine compound (a2-1) represented by the formula (2) and a diamine compound (a2-2) represented by the formula (3). In addition, the diamine component (a2) may also include other diamine compounds (a2-3). Diamine compound ( a2-1 )

二胺化合物(a2-1)為由式(2)表示的化合物。式(2) 式(2)中,Ra 表示-CH2 -、-O-、-NH-、-N(CH3 )-、-CONH-、-NHCO-、-CH2 O-、-COO-、-OCO-、-CON(CH3 )-或-N(CH3 )CO-。Ra 可藉一般有機合成方法形成,但由合成容易性之觀點而言,以-CH2 -、-O-、-NH-、-NHCO-、-CH2 O-或-COO-為較佳。Rb 表示碳數為1至20的未經取代或經氟原子取代的直鏈狀伸烷基,且所述伸烷基中任意的-CH2 -可經-CF2 -、-CH=CH-或下述的取代基取代,所述取代基包括:-O-、-COO-、-NHCO-、-NH-、碳環基或雜環基,其中,當兩個以上的-CH2 -經所述取代基取代時,所述取代基不相鄰接。較佳地,Rb 表示碳數為1至20的直鏈狀伸烷基,更佳地,Rb 表示碳數為2至8的直鏈狀伸烷基。 所述碳環基可列舉以下構造,但不限於此。所述雜環基可列舉以下構造,但不限於此。Rc 表示-CH2 -、-O-、-NH-、-N(CH3 )-、-CONH-、-NHCO-、-CH2 O-、-COO-、-OCO-、-CON(CH3 )-、-N(CH3 )CO-、碳環基或雜環基。較佳地,Rc 表示-CH2 -、-O-、-NH-、-NHCO-、-COO-、-OCO-、碳環基或雜環基,該碳環基及雜環基之較佳具體例與Rb 相同;更佳地,Rc 表示-CH2 -、-O-、-NH-、-NHCO-、-COO-或-OCO-。 Rd 表示乙烯苯基、-CRe =CH2 、碳環基、雜環基、或由下述結構式表示的基團,Re 表示氫原子或可經氟原子取代之甲基。 較佳地,Rd 表示乙烯苯基、-CH=CH2 、-C(CH3 )=CH2 或下述的基團。 The diamine compound (a2-1) is a compound represented by formula (2). In Formula (2) Formula (2), R a represents -CH 2 -, - O -, - NH -, - N (CH 3) -, - CONH -, - NHCO -, - CH 2 O -, - COO -, -OCO-, -CON (CH 3 )-or -N (CH 3 ) CO-. R a can be formed by a general organic synthesis method, but from the viewpoint of ease of synthesis, -CH 2- , -O-, -NH-, -NHCO-, -CH 2 O-, or -COO- is preferred. . R b represents an unsubstituted or fluorine-substituted linear alkylene group having a carbon number of 1 to 20, and any -CH 2 -in the alkylene group may be -CF 2- , -CH = CH -Or the following substituents, which include: -O-, -COO-, -NHCO-, -NH-, carbocyclyl or heterocyclic group, wherein when two or more -CH 2- When substituted with the substituent, the substituents are not adjacent. Preferably, R b represents a linear alkylene group having 1 to 20 carbon atoms, and more preferably, R b represents a linear alkylene group having 2 to 8 carbon atoms. Examples of the carbocyclic group include the following structures, but are not limited thereto. Examples of the heterocyclic group include the following structures, but are not limited thereto. R c represents -CH 2- , -O-, -NH-, -N (CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -COO-, -OCO-, -CON (CH 3) -, - N (CH 3) CO-, carbocyclic group or heterocyclic group. Preferably, R c represents -CH 2- , -O-, -NH-, -NHCO-, -COO-, -OCO-, carbocyclyl or heterocyclic group. Preferred examples are the same as those of R b ; more preferably, R c represents -CH 2- , -O-, -NH-, -NHCO-, -COO-, or -OCO-. R d represents vinylphenyl, -CR e = CH 2, a carbocyclic group, a heterocyclic group, or a group represented by the following structural formula, R e represents a hydrogen atom or a methyl group may be substituted by fluorine atoms. Preferably, R d represents a phenyl vinyl, -CH = CH 2, -C ( CH 3) = CH 2 or the following groups.

式(2)中,兩個胺基(-NH2 )的鍵結位置並無特別限制。具體而言,可列舉在苯環上相對於側鏈之鍵結基而鍵結於2,3位置、2,4位置、2,5位置、2,6位置、3,4位置、3,5位置。其中,就合成聚醯胺酸時之反應性的觀點而言,較佳為2,4位置、2,5位置、或3,5位置。就考量合成二胺化合物時之容易性的觀點而言,更佳為2,4位置或3,5位置。In formula (2), the bonding position of two amine groups (-NH 2 ) is not particularly limited. Specifically, the benzene ring may be bonded to a 2,3 position, a 2,4 position, a 2,5 position, a 2,6 position, a 3,4 position, or a 3,5 position relative to a bonding group of a side chain. position. Among these, from the viewpoint of reactivity when synthesizing polyamic acid, the 2,4 position, the 2,5 position, or the 3,5 position is preferred. From the viewpoint of considering the ease when synthesizing a diamine compound, it is more preferably a 2,4 position or a 3,5 position.

具體而言,可列舉以下化合物,但不限於此。 式中,X表示-C-、-O-、-NHCO-、-CONH-、-COO-、-OCO-或-NH-,l、m、及n各自獨立表示0至20的整數。Specific examples include the following compounds, but are not limited thereto. In the formula, X represents -C-, -O-, -NHCO-, -CONH-, -COO-, -OCO-, or -NH-, and l, m, and n each independently represent an integer of 0 to 20.

二胺化合物(a2-1)可以使用單獨一種或者組合多種來使用。基於二胺組份(a2)的總使用量為100莫耳,二胺化合物(a2-1)的使用量可為5至70莫耳,較佳為10莫耳至60莫耳,更佳為15莫耳至50莫耳。當液晶配向膜中二胺化合物(a2-1)的使用量在此範圍內時,則由該液晶配向膜所製得之液晶顯示元件中的液晶層裡,所殘留的未反應的聚合性化合物較少。二胺化合物( a2-2 The diamine compound (a2-1) can be used alone or in combination. Based on the total usage of the diamine component (a2) is 100 mol, and the usage of the diamine compound (a2-1) may be 5 to 70 mol, preferably 10 mol to 60 mol, and more preferably 15 mol to 50 mol. When the usage amount of the diamine compound (a2-1) in the liquid crystal alignment film is within this range, the unreacted polymerizable compound remaining in the liquid crystal layer in the liquid crystal display element obtained from the liquid crystal alignment film less. Diamine compound ( a2-2 )

二胺化合物(a2-2)為由式(3)表示的化合物。式(3) 式(3)中,R3 表示-O-、,或者;R4 表示含甾基團、碳數為2至30的伸烷基或由式(3-1)表示的有機基團:式(3-1) 式(3-1)中,R5 表示氫原子、氟原子或甲基;R6 、R7 或R8 各自獨立表示單鍵、-O-、或碳數為1至3的伸烷基;R9 表示,其中,R11 及R12 各自獨立表示氫原子、氟原子或甲基;R10 表示氫原子、氟原子、碳數為1至12的烷基、碳數為1至12的氟烷基、碳數為1至12的烷氧基、-OCH2 F、-OCHF2 或-OCF3 ;a表示1或2;b、c及d各自獨立表示0至4的整數;e、f及g各自獨立表示0至3的整數,且e+f+g≧1;h及i各自獨立表示1或2;當存在多個R5 、R6 、R7 、R8 、R9 、R10 、R11 或R12 的情況下,多個R5 、R6 、R7 、R8 、R9 、R10 、R11 或R12 各自為相同或不同。The diamine compound (a2-2) is a compound represented by the formula (3). Formula (3) In Formula (3), R 3 represents -O-, , , , ,or ; R 4 represents a steroid-containing group, an alkylene group having 2 to 30 carbon atoms, or an organic group represented by the formula (3-1): Formula (3-1) In formula (3-1), R 5 represents a hydrogen atom, a fluorine atom or a methyl group; R 6 , R 7 or R 8 each independently represents a single bond, -O-, , , , , Or an alkylene group having 1 to 3 carbon atoms; R 9 represents or Wherein R 11 and R 12 each independently represent a hydrogen atom, a fluorine atom or a methyl group; R 10 represents a hydrogen atom, a fluorine atom, an alkyl group having 1 to 12 carbon atoms, a fluoroalkyl group having 1 to 12 carbon atoms, Alkoxy, -OCH 2 F, -OCHF 2 or -OCF 3 having a carbon number of 1 to 12; a represents 1 or 2; b, c, and d each independently represent an integer of 0 to 4; e, f, and g each Independently represents an integer from 0 to 3, and e + f + g ≧ 1; h and i each independently represent 1 or 2; when there are multiple R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R In the case of 11 or R 12 , a plurality of R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 or R 12 are each the same or different.

二胺化合物(a2-2)的具體例包括但不限於2,4-二胺基苯基甲酸乙酯(2,4-diaminophenyl ethyl formate)、3,5-二胺基苯基甲酸乙酯(3,5-diaminophenyl ethyl formate)、2,4-二胺基苯基甲酸丙酯(2,4-diaminophenyl propyl formate)、3,5-二胺基苯基甲酸丙酯(3,5-diaminophenyl propyl formate)、1-十二烷氧基-2,4-二胺基苯(1-dodecoxy-2,4-diaminobenzene)、1-十六烷氧基-2,4-二胺基苯(1-hexadecoxy-2,4-diaminobenzene)、1-十八烷氧基-2,4-二胺基苯(1-octadecoxy-2,4-diaminobenzene)、由式(3-1-1)至式(3-1-29)表示的化合物,或上述化合物的組合。 式(3-1-1) 式(3-1-2) 式(3-1-3) 式(3-1-4) 式(3-1-5) 式(3-1-6) 式(3-1-7) 式(3-1-8) 式(3-1-9) 式(3-1-10) 式(3-1-11) 式(3-1-12)式(3-1-13)式(3-1-14)式(3-1-15)式(3-1-16)式(3-1-17)式(3-1-18) 式(3-1-19) 式(3-1-20) 式(3-1-21) 式(3-1-22) 式(3-1-23) 式(3-1-24) 式(3-1-25) 式(3-1-26)式(3-1-27)式(3-1-28)式(3-1-29) 式(3-1-1)至式(3-1-29)中,R13 表示碳數為1至10的烷基或碳數為1至10的烷氧基,R14 表示氫原子、碳數為1至10的烷基或碳數為1至10的烷氧基。式(3-1-23)至式(3-1-26)中,j表示3至12的整數。Specific examples of the diamine compound (a2-2) include, but are not limited to, 2,4-diaminophenyl ethyl formate, 3,5-diaminophenyl ethyl formate ( 3,5-diaminophenyl ethyl formate), 2,4-diaminophenyl propyl formate, 3,5-diaminophenyl propyl formate), 1-dodecoxy-2,4-diaminobenzene, 1-dodecoxy-2,4-diaminobenzene, 1-dodecoxy-2,4-diaminobenzene hexadecoxy-2,4-diaminobenzene), 1-octadecoxy-2,4-diaminobenzene, from formula (3-1-1) to formula (3 -1-29), or a combination thereof. Equation (3-1-1) Equation (3-1-2) Equation (3-1-3) Equation (3-1-4) Formula (3-1-5) Formula (3-1-6) Formula (3-1-7) Formula (3-1-8) Formula (3-1-9) Formula (3-1-10) Formula (3-1-11) Formula (3-1-12) Formula (3-1-13) Formula (3-1-14) Formula (3-1-15) Formula (3-1-16) Formula (3-1-17) Formula (3-1-18) Formula (3-1-19) Formula (3-1-20) Formula (3-1-21) Formula (3-1-22) Formula (3-1-23) Formula (3-1-24) Formula (3-1-25) Formula (3-1-26) Formula (3-1-27) Formula (3-1-28) Formula (3-1-29) In Formulas (3-1-1) to (3-1-29), R 13 represents an alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms. R 14 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or an alkoxy group having 1 to 10 carbon atoms. In the formulae (3-1-23) to (3-1-26), j represents an integer of 3 to 12.

上述之二胺化合物(a2-2)中,較佳為1-十二烷氧基-2,4-二胺基苯、1-十六烷氧基-2,4-二胺基苯、1-十八烷氧基-2,4-二胺基苯、式(3-1-3)、式(3-1-8)至式(3-1-15)、式(3-1-19)及式(3-1-23)。Among the above diamine compounds (a2-2), 1-dodecyloxy-2,4-diaminobenzene, 1-hexadecyloxy-2,4-diaminobenzene, 1 -Octadecyloxy-2,4-diaminobenzene, formula (3-1-3), formula (3-1-8) to formula (3-1-15), formula (3-1-19 ) And formula (3-1-23).

二胺化合物(a2-2)可以使用單獨一種或者組合多種來使用。基於二胺組份(a2)的總使用量為100莫耳,二胺化合物(a2-2)的使用量可為3至50莫耳,較佳為5莫耳至40莫耳,更佳為10莫耳至30莫耳。當液晶配向膜使用二胺化合物(a2-2)時,則由該液晶配向膜所製得之液晶顯示元件具有較佳的長期信賴性。其他二胺化合物( a2-3 The diamine compound (a2-2) can be used alone or in combination. Based on the total usage of the diamine component (a2) is 100 mol, and the usage of the diamine compound (a2-2) may be 3 to 50 mol, preferably 5 mol to 40 mol, and more preferably 10 mol to 30 mol. When the diamine compound (a2-2) is used for the liquid crystal alignment film, the liquid crystal display element prepared from the liquid crystal alignment film has better long-term reliability. Other diamine compounds ( a2-3 )

除上述之二胺化合物(a2-1)及二胺化合物(a2-2)外,本發明之二胺組份(a2)亦可選擇性地混合使用其他二胺化合物(a2-3)。其他二胺化合物(a2-3)可包括但不限於1,2-二胺基乙烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、4,4’-二胺基庚烷、1,3-二胺基-2,2-二甲基丙烷、1,6-二胺基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、1,9-二胺基-5-甲基壬烷、2,11-二胺基十二烷、1,12-二胺基十八烷、1,2-雙(3-胺基丙氧基)乙烷、4,4’-二胺基二環己基甲烷、4,4’-二胺基-3,3’-二甲基二環己基胺、1,3-二胺基環己烷、1,4-二胺基環己烷、異佛爾酮二胺(isophoronediamine)、四氫二環戊二烯二胺、三環[6‧2‧1‧02,7 ]-十一碳烯二甲基二胺、4,4’-亞甲基雙(環己基胺)、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基乙烷、4,4’-二胺基二苯基碸、4,4’-二胺基苯甲醯苯胺、4,4’-二胺基二苯基醚、3,4’-二胺基二苯基醚、1,5-二胺基萘、5-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氫茚、6-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氫茚、六氫-4,7-甲橋伸氫茚基二亞甲基二胺、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、4,4’-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4-胺基苯基)-10-氫蒽、9,10-雙(4-胺基苯基)蒽(9,10-bis(4-aminophenyl) anthracene)、2,7-二胺基茀、9,9-雙(4-胺基苯基)茀、4,4’-亞甲基-雙(2-氯苯胺)、4,4’-(對-伸苯基異亞丙基)雙苯胺、4,4’-(間-伸苯基異亞丙基)雙苯胺、2,2’-雙[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4’-雙[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、5-[4-(4-正戊烷基環己基)環己基]苯基-亞甲基-1,3-二胺基苯(5-[4-(4-n- pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene)或1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷(1,1- bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane、由式(4-1)至式(4-23)表示的化合物,或上述化合物的組合。In addition to the diamine compound (a2-1) and the diamine compound (a2-2) described above, the diamine component (a2) of the present invention can also be used by selectively mixing other diamine compounds (a2-3). Other diamine compounds (a2-3) may include, but are not limited to, 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diamine Pentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,10-diamine Decane, 4,4'-diaminoheptane, 1,3-diamino-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1 , 7-diamino-2,5-dimethylheptane, 1,7-diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1,9-diamino-5-methylnonane, 2,11-diaminododecane, 1,12-diaminooctadecane, 1,2-bis (3-aminopropoxy ) Ethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diamino-3,3'-dimethyldicyclohexylamine, 1,3-diaminocyclohexane, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadiene diamine, tricyclo [6‧2‧1‧0 2,7 ] -undecene Dimethyldiamine, 4,4'-methylenebis (cyclohexylamine), 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4, 4'-diaminodiphenylphosphonium, 4,4'-diaminobenzidineaniline, 4,4'-diamine Diphenyl ether, 3,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 5-amino-1- (4'-aminophenyl) -1,3,3 -Trimethylhydroindene, 6-amino-1- (4'-aminophenyl) -1,3,3-trimethylhydroindene, hexahydro-4,7-methyl bridged indenyl di Methylene diamine, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4'-diaminobenzophenone, 2,2-bis [4- (4-Aminophenoxy) phenyl] propane, 2,2-bis [4- (4-aminophenoxy) phenyl] hexafluoropropane, 2,2-bis (4-amine Phenyl) hexafluoropropane, 2,2-bis [4- (4-aminophenoxy) phenyl] fluorene, 1,4-bis (4-aminophenoxy) benzene, 1,3- Bis (4-aminophenoxy) benzene, 1,3-bis (3-aminophenoxy) benzene, 9,9-bis (4-aminophenyl) -10-hydroanthracene, 9,10 -Bis (4-aminophenyl) anthracene (9,10-bis (4-aminophenyl) anthracene), 2,7-diaminofluorene, 9,9-bis (4-aminophenyl) fluorene, 4 , 4'-methylene-bis (2-chloroaniline), 4,4 '-(p-phenylene isopropylidene) bisaniline, 4,4'-(m-phenylene isopropylidene) ) Bisaniline, 2,2'-bis [4- (4-amino-2-trifluoromethylphenoxy) phenyl] hexafluoropropane, 4,4'-bis [(4-amino-2 -Trifluoromethyl) phenoxy] -octafluorobiphenyl, 5- [4- (4-n-pentyl Cyclohexyl) cyclohexyl] phenyl-methylene-1,3-diaminobenzene (5- [4- (4-n-pentylcyclohexyl) cyclohexyl] phenylmethylene-1,3-diaminobenzene) or 1,1- Bis [4- (4-aminophenoxy) phenyl] -4- (4-ethylphenyl) cyclohexane (1,1-bis [4- (4-aminophenoxy) phenyl] -4- ( 4-ethylphenyl) cyclohexane, a compound represented by the formula (4-1) to the formula (4-23), or a combination thereof.

式(4-1) 式(4-1)中,R3 如前所述,且R15 代表三氟甲基、氟基,或著衍生自吡啶、嘧啶、三嗪、哌啶或哌嗪等含氮原子環狀結構的一價基團。 Formula (4-1) In formula (4-1), R 3 is as described above, and R 15 represents a trifluoromethyl group, a fluoro group, or is derived from pyridine, pyrimidine, triazine, piperidine, piperazine, etc. A monovalent group containing a nitrogen atom ring structure.

式(4-2) 式(4-2)中,R3 如前所述,且R16 及R17 代表伸脂肪族環、伸芳香族環或伸雜環基團,且R18 代表碳數為3至18之烷基、碳數為3至18之烷氧基、碳數為1至5之氟烷基、碳數為1至5之氟烷氧基、氰基或鹵素原子。 Formula (4-2) In formula (4-2), R 3 is as described above, and R 16 and R 17 represent an aliphatic ring, an aromatic ring, or a heterocyclic group, and R 18 represents a carbon number It is an alkyl group of 3 to 18, an alkoxy group of 3 to 18 carbons, a fluoroalkyl group of 1 to 5 carbon atoms, a fluoroalkoxy group of 1 to 5 carbon atoms, a cyano group or a halogen atom.

由式(4-2)表示的其他二胺化合物(a2-3)較佳是選自由下述式(4-2-1)至式(4-2-5)表示的化合物:式(4-2-1)式(4-2-2)式(4-2-3)式(4-2-4)式(4-2-5)The other diamine compound (a2-3) represented by the formula (4-2) is preferably selected from compounds represented by the following formulae (4-2-1) to (4-2-5): Formula (4-2-1) Formula (4-2-2) Formula (4-2-3) Formula (4-2-4) Formula (4-2-5)

式(4-3) 式(4-3)中,R19 表示氫原子、碳數為1至5的醯基、碳數為1至5的烷基、碳數為1至5的烷氧基或鹵素,且每個重複單元中的R19 可為相同或不同,且p1 為1至3的整數。由式(4-3)表示的其他二胺化合物(a2-3)較佳是選自於(1)當p1 為1時:對-二胺苯、間-二胺苯、鄰-二胺苯或2,5-二胺甲苯等;(2)當p1 為2時:4,4’-二胺基聯苯、2,2’-二甲基-4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基聯苯、3,3’-二氯-4,4’-二胺基聯苯、2,2’,5,5’-四氯-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基-5,5’-二甲氧基聯苯或4,4’-二胺基-2,2’-雙(三氟甲基)聯苯等;(3)當p1 為3時:1,4-雙(4’-胺基苯基)苯等。其中,更佳為對-二胺苯、2,5-二胺甲苯、4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯及1,4-雙(4’-胺基苯基)苯。 Formula (4-3) In Formula (4-3), R 19 represents a hydrogen atom, a fluorenyl group having 1 to 5 carbon atoms, an alkyl group having 1 to 5 carbon atoms, and an alkoxy group having 1 to 5 carbon atoms. Or halogen, and R 19 in each repeating unit may be the same or different, and p 1 is an integer of 1 to 3. The other diamine compound (a2-3) represented by the formula (4-3) is preferably selected from (1) when p 1 is 1: p-diaminebenzene, m-diaminebenzene, ortho-diamine Benzene or 2,5-diamine toluene, etc .; (2) when p 1 is 2: 4,4'-diamine-based biphenyl, 2,2'-dimethyl-4,4'-diamine-based Benzene, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2'-dichloro -4,4'-diaminobiphenyl, 3,3'-dichloro-4,4'-diaminobiphenyl, 2,2 ', 5,5'-tetrachloro-4,4'-di Aminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl or 4,4'-diamino-2,2'-bis ( (3) When p 1 is 3: 1,4-bis (4'-aminophenyl) benzene and the like. Of these, p-diaminebenzene, 2,5-diaminetoluene, 4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl are more preferred. And 1,4-bis (4'-aminophenyl) benzene.

式(4-4) 式(4-4)中,p2 為2至12的整數。 Formula (4-4) In Formula (4-4), p 2 is an integer of 2-12.

式(4-5) 式(4-5)中,p3 為1至5的整數。式(4-5)較佳為4,4’-二胺基-二苯基硫醚。 Formula (4-5) In Formula (4-5), p 3 is an integer of 1 to 5. Formula (4-5) is preferably 4,4'-diamino-diphenylsulfide.

式(4-6) 式(4-6)中,R20 及R22 為相同或不同,且分別表示二價有機基團;R21 表示衍生自吡啶、嘧啶、三嗪、哌啶或哌嗪等含氮原子環狀結構的二價基團。 Formula (4-6) In formula (4-6), R 20 and R 22 are the same or different and each represents a divalent organic group; R 21 represents a derivative derived from pyridine, pyrimidine, triazine, piperidine, or piperazine A divalent group having a cyclic structure such as a nitrogen atom.

式(4-7) 式(4-7)中,R23 、R24 、R25 及R26 為相同或不同,且分別表示碳數為1至12的烴基;p4 代表1至3的整數;p5 代表1至20的整數。 Formula (4-7) In formula (4-7), R 23 , R 24 , R 25, and R 26 are the same or different, and each represents a hydrocarbon group having 1 to 12 carbons; p 4 represents an integer of 1 to 3 ; P 5 represents an integer from 1 to 20.

式(4-8) 式(4-8)中,R27 表示氧原子或伸環己烷基;R28 表示-CH2 -;R29 表示伸苯基或伸環己烷基;R30 表示氫原子或庚基。由式(4-8)表示的其他二胺化合物(a2-3)較佳為選自於如下述式(4-8-1)及式(4-8-2)所表示的化合物:式(4-8-1)式(4-8-2) Formula (4-8) In formula (4-8), R 27 represents an oxygen atom or a cyclohexane group; R 28 represents -CH 2- ; R 29 represents a phenyl group or a cyclohexane group; and R 30 represents Hydrogen atom or heptyl. The other diamine compound (a2-3) represented by the formula (4-8) is preferably selected from compounds represented by the following formula (4-8-1) and formula (4-8-2): Formula (4-8-1) Formula (4-8-2)

由式(4-9)至式(4-15)表示的其他二胺化合物(a2-3)如下所示:式(4-9)式(4-10)式(4-11)式(4-12)式(4-13)式(4-14)式(4-15) 式(4-9)至式(4-15)中,R31 較佳為碳數為1至10之烷基或碳數為1至10之烷氧基,R32 較佳為氫原子、碳數為1至10之烷基或碳數為1至10之烷氧基。The other diamine compounds (a2-3) represented by the formula (4-9) to the formula (4-15) are as follows: Formula (4-9) Formula (4-10) Formula (4-11) Formula (4-12) (4-13) Formula (4-14) Formula (4-15) In formulas (4-9) to (4-15), R 31 is preferably an alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms, and R 32 is more than A hydrogen atom, an alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms is preferred.

由式(4-16)至式(4-23)表示的其他二胺化合物(a2-3)如下所示:式(4-16)式(4-17)式(4-18)式(4-19)式(4-20)式(4-21)式(4-22)式(4-23)The other diamine compounds (a2-3) represented by the formula (4-16) to the formula (4-23) are as follows: (4-16) (4-17) (4-18) (4-19) Formula (4-20) Formula (4-21) (4-22) (4-23)

上述之其他二胺化合物(a2-3)中,較佳為1,2-二胺基乙烷、4,4’-二胺基二環己基甲烷、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷、對-二胺苯、間-二胺苯、鄰-二胺苯、由式(4-8-1)所表示的化合物,或上述化合物的組合。Among the other diamine compounds (a2-3), 1,2-diaminoethane, 4,4'-diaminodicyclohexylmethane, and 4,4'-diaminodiphenyl are preferred. Methane, 4,4'-diaminodiphenyl ether, 5- [4- (4-n-pentylcyclohexyl) cyclohexyl] phenylmethylene-1,3-diaminobenzene, 1, 1-bis [4- (4-aminophenoxy) phenyl] -4- (4-ethylphenyl) cyclohexane, p-diaminebenzene, m-diaminebenzene, o-diaminebenzene A compound represented by the formula (4-8-1), or a combination thereof.

其他二胺化合物(a2-3)可以使用單獨一種或者組合多種來使用。基於二胺組份(a2)的總使用量為100莫耳,其他二胺化合物(a2-3)的使用量可為0至70莫耳,較佳為5莫耳至60莫耳,更佳為10莫耳至50莫耳。The other diamine compounds (a2-3) can be used alone or in combination. Based on the total usage of the diamine component (a2) is 100 mol, and the usage of other diamine compounds (a2-3) may be 0 to 70 mol, preferably 5 mol to 60 mol, more preferably It is 10 mol to 50 mol.

本發明之具有馬來醯胺酸基的化合物(A)的製造方法並無限定,一般而言,是由馬來酸酐衍生物(a1)及二胺組份(a2)於有機溶劑中反應而得。所述有機溶劑只要可溶解反應物,在種類上並無特別的限制。有機溶劑的具體例可列舉:N-甲基-2-吡咯烷酮、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、二甲基亞碸、N-甲基己內醯胺、γ-丁內酯、丙酮、甲基乙基酮、乙二醇正丁基醚、二噁烷、四氫呋喃,或上述化合物的組合。溶劑可以使用單獨一種或者組合多種來使用。馬來酸酐衍生物(a1)與二胺組份(a2)的反應溫度一般為0~100℃,較佳為0~80℃,更佳為0~70℃。反應時間一般為1~5小時,較佳為2~4小時。The method for producing the maleic acid-containing compound (A) of the present invention is not limited. Generally, it is obtained by reacting a maleic anhydride derivative (a1) and a diamine component (a2) in an organic solvent. Got. There is no particular limitation on the kind of the organic solvent as long as it can dissolve the reactants. Specific examples of the organic solvent include N-methyl-2-pyrrolidone, N, N-dimethylacetamide, N, N-dimethylformamide, dimethylmethylene, and N-methylhexanone. Lactam, γ-butyrolactone, acetone, methyl ethyl ketone, ethylene glycol n-butyl ether, dioxane, tetrahydrofuran, or a combination thereof. The solvent may be used singly or in combination. The reaction temperature of the maleic anhydride derivative (a1) and the diamine component (a2) is generally 0 to 100 ° C, preferably 0 to 80 ° C, and more preferably 0 to 70 ° C. The reaction time is generally 1 to 5 hours, preferably 2 to 4 hours.

馬來酸酐衍生物(a1)與二胺組份(a2)的使用比例,以馬來酸酐衍生物(a1)之酸酐基與二胺組份(a2)之胺基的莫耳數比為基準,一般為0.5至2.5,較佳為0.8至2.0,更佳為1.0至1.8。The ratio of the maleic anhydride derivative (a1) to the diamine component (a2) is based on the molar ratio of the acid anhydride group of the maleic anhydride derivative (a1) to the amine group of the diamine component (a2). Is generally 0.5 to 2.5, preferably 0.8 to 2.0, and more preferably 1.0 to 1.8.

本發明的具有馬來醯胺酸基的化合物(A),根據凝膠滲透色層分析法(Gel Permeation Chromatography,GPC)所測得經聚苯乙烯換算的重量平均分子量為2,500至150,000,較佳為3,500至100,000,更佳為4,500至80,000。聚合物( B The compound (A) having a maleic acid group according to the present invention has a weight average molecular weight measured in terms of polystyrene measured in accordance with Gel Permeation Chromatography (GPC) of 2,500 to 150,000, preferably It is 3,500 to 100,000, and more preferably 4,500 to 80,000. Polymer ( B )

本發明之聚合物(B)是選自由聚縮合反應而得的聚酯、聚酯亞胺、聚醯胺醯亞胺酸、聚醯胺醯亞胺、聚醯胺酸酯、聚醯胺及聚醯亞胺系聚合物中至少一種的聚合物。其中,聚醯亞胺系聚合物包含聚醯胺酸(B-1)及/或聚醯亞胺(B-2)及/或聚醯亞胺系嵌段共聚合物(B-3)。The polymer (B) of the present invention is selected from the group consisting of polyesters, polyesterimines, polyamidoimines, polyamidoimides, polyamidoimides, polyamidoamines, and A polymer of at least one of polyfluorene-based polymers. Among them, the polyfluorene-imide-based polymer includes a polyfluorene-acid (B-1) and / or a polyfluorene-imide (B-2) and / or a polyfluorine-based block copolymer (B-3).

而該聚醯亞胺系嵌段共聚合物(B-3)包含聚醯胺酸嵌段共聚合物(B-3-1)及/或聚醯亞胺嵌段共聚合物(B-3-2)及/或聚醯胺酸-聚醯亞胺嵌段共聚合物(B-3-3)。The polyfluorene-based block copolymer (B-3) includes a polyfluorine-based block copolymer (B-3-1) and / or a polyfluorene-based block copolymer (B-3). -2) and / or polyamido-polyamido block copolymer (B-3-3).

該聚醯亞胺系嵌段共聚合物(B-3)例如式(5-1)所表示的第1聚醯胺酸嵌段與構造相異之第2聚醯胺酸嵌段之聚醯胺酸嵌段共聚合物(B-3-1);式(5-1) 式中,J1 、J2 表示相同或相異之4價有機基;K1 、K2 表示相同或相異之2價有機基;J1 、J2 為相同時,K1 、K2 為相異,反之亦然,或者是J1 、J2 及K1 、K2 同時皆相異;x1 及y1 各自獨立表示1至2,000的整數,z表示1至100的整數。The polyfluorene imide-based block copolymer (B-3) is, for example, a polyfluorene of a first polyfluorene acid block represented by formula (5-1) and a second polyfluorine acid block having a different structure. Amino acid block copolymer (B-3-1); Formula (5-1) In the formula, J 1 and J 2 represent the same or different divalent organic groups; K 1 and K 2 represent the same or different divalent organic groups; when J 1 and J 2 are the same, K 1 and K 2 are different and vice versa, or J 1 , J 2 and K 1 and K 2 are different at the same time; x 1 and y 1 each independently represent an integer from 1 to 2,000, and z represents 1 to 100 Integer.

式(5-2)所表示的第1聚醯亞胺嵌段與構造相異之第2聚醯亞胺嵌段之聚醯亞胺嵌段共聚合物(B-3-2);式(5-2) 式中,J3 、J4 表示相同或相異之4價有機基;K3 、K4 表示相同或相異之2價有機基;J3 、J4 為相同時,K3 、K4 為相異,反之亦然,或者是J3 、J4 及K3 、K4 同時皆相異;x1 及y1 各自獨立表示1至2,000的整數,z表示1至100的整數。Polyimide block copolymer (B-3-2) of the first polyfluorene imine block represented by the formula (5-2) and the second polyfluorene imine block having a different structure; Formula (5-2) In the formula, J 3 and J 4 represent the same or different divalent organic groups; K 3 and K 4 represent the same or different divalent organic groups; when J 3 and J 4 are the same, K 3 and K 4 are different and vice versa, or J 3 , J 4 and K 3 and K 4 are different at the same time; x 1 and y 1 each independently represent an integer from 1 to 2,000, and z represents 1 to 100 Integer.

以及式(5-3)所表示之聚醯胺酸嵌段與聚醯亞胺嵌段之聚醯胺酸-聚醯亞胺嵌段共聚合物(B-3-3)。式(5-3) 式中,J5 、J6 表示相同或相異之4價有機基;K5 、K6 表示相同或相異之2價有機基;J5 、J6 為相同時,K5 、K6 為相異,反之亦然,或者是J5 、J6 及K5 、K6 同時皆相異;x1 及y1 各自獨立表示1至2,000的整數,z表示1至100的整數。And a polyamic acid-polyfluorene imine block copolymer (B-3-3) of a polyfluorene acid block and a polyfluorine imine block represented by formula (5-3). Formula Formula (5-3) in, J 5, J 6 4 represents the same or different monovalent organic group; K 5, K 6 of the same or different divalent organic group; J 5, J 6 is the same, K 5 and K 6 are different and vice versa, or J 5 , J 6 and K 5 and K 6 are different at the same time; x 1 and y 1 each independently represent an integer from 1 to 2,000, and z represents 1 to 100 Integer.

本發明之聚合物(B)較佳為聚醯亞胺系聚合物。聚醯亞胺系聚合物所使用之四羧酸二酐化合物及二胺化合物並無特別限定。四羧酸二酐化合物之具體例包括但不限於乙烷四羧酸二酐、丁烷四羧酸二酐、1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、1,2,5,6-環己烷四羧酸二酐、3,3’,4,4’-二環己基四羧酸二酐、二環庚烷四羧酸二酐、3,3’-二環己基-1,1’,2,2’-四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、3,5,6-三羧基降冰片烷-2-醋酸二酐(3,5,6-tricarboxynorbornane-2-acetic dianhydride、2,3,4,5-四氫呋喃四羧酸二酐、四環[6.2.11 ,3 .02,7 ]十二烷-4,5,9,10-四羧酸二酐、3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、1,3,3a,4,5,9b-六氫-5(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮(1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione)、1,3,3a,4,5,9b-六氫-5-甲基-5(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-乙基-5(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-甲基-5(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-乙基-5(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-甲基-5(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-乙基-5(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5,8-二甲基-5(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、5-(2,5-二側氧基四氫呋喃基)-3-甲基-3-環己烯-1,2-二羧酸二酐、二環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐、二環[3.3.0]-辛烷-2,4,6,8-四羧酸二酐、3-氧雜二環[3.2.1]辛烷-2,4-二酮-6-螺-3’-(四氫呋喃-2’,5’-二酮)(3-oxabicyclo[3.2.1]-octane-2,4-dione-6-spiro-3’-(tetrahydrofuran-2’,5’-dione))、苯均四羧酸二酐、2,3,3’,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐、2,2’,3,3’-聯苯四羧酸二酐、2,3,3’,4-聯苯四羧酸二酐、3,3’,4,4’-聯苯四羧酸二酐、3,3’,4,4’-聯苯碸四羧酸二酐、1,2,5,6-萘四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、2,3,6,7-蒽四羧酸二酐、1,2,5,6-蒽四羧酸二酐、雙(3,4-二羧基苯基)醚二酐、雙(3,4-二羧基苯基)碸二酐、雙(3,4-二羧基苯基)甲烷二酐、2,2-雙(3,4-二羧基苯基)丙烷二酐、1,1,1,3,3,3-六氟-2,2-雙(3,4-二羧基苯基)丙烷二酐、雙(3,4-二羧基苯基)二甲基矽烷二酐、雙(3,4-二羧基苯基)二苯基矽烷二酐、2,3,4,5-吡啶四羧酸二酐、2,6-雙(3,4-二羧基苯基)吡啶二酐、3,3’,4,4’-二甲基二苯基矽烷四羧酸二酐、3,3’,4,4’-四苯基矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、4,4’-雙(3,4-二羧基苯甲基)二苯基甲烷二酐、4,4’-雙(3,4-二羧基苯甲基)二苯基乙烷二酐、4,4’-雙(3,4-二羧基苯甲基)二苯基丙烷二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基甲烷二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基乙烷二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基丙烷二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基硫醚二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基碸二酐、3,3’,4,4’-全氟亞丙基二酞酸二酐、3,3’,4,4’-全氟異亞丙基二酞酸二酐、雙(酞酸)苯基氧化膦二酐(bis(phthalic acid)phenylphosphine oxide dianhydride)、雙(酞酸)苯基氧化硫二酐(bis(phthalic acid)phenylsulphine oxide dianhydride)、對-伸苯基-雙(三苯基酞酸)二酐(p-phenylene-bis(triphenylphthalic acid)dianhydride)、間-伸苯基-雙(三苯基酞酸)二酐、雙(三苯基酞酸)-4,4’-二苯基醚二酐、雙(三苯基酞酸)-4,4’-二苯基甲烷二酐、乙二醇-雙(無水偏苯三甲酸酐酯)(ethylene glycol-bis(anhydrotrimellitate))、丙二醇-雙(無水偏苯三甲酸酐酯)、1,4-丁二醇-雙(無水偏苯三甲酸酐酯)、1,6-己二醇-雙(無水偏苯三甲酸酐酯)、1,8-辛二醇-雙(無水偏苯三甲酸酐酯)、2,2-雙(4-羥基苯基)丙烷-雙(無水偏苯三甲酸酐酯),式(6-1)至式(6-6)所示的四羧酸二酐化合物,或上述化合物的組合。上述化合物可使用單獨一種或者組合多種來使用。式(6-1)式(6-2) 式中,R41 以及R43 各自獨立表示含有芳香環的2價有機基,R42 以及R44 各自獨立表示氫原子或烷基,以複數存在的R42 以及R44 分別可為相同或相異。The polymer (B) of the present invention is preferably a polyfluorene-imide-based polymer. The tetracarboxylic dianhydride compound and the diamine compound used in the polyfluorene imide-based polymer are not particularly limited. Specific examples of tetracarboxylic dianhydride compounds include, but are not limited to, ethane tetracarboxylic dianhydride, butane tetracarboxylic dianhydride, 1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2- Dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3- Dichloro-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1 , 2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 1,2,5,6-cyclohexanetetracarboxylic dianhydride, 3,3 ', 4,4'-dicyclohexyltetracarboxylic dianhydride, dicycloheptanetetracarboxylic dianhydride, 3,3'-dicyclohexyl-1,1', 2,2'-tetracarboxylic Acid dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 3,5,6-tricarboxynorbornane-2-acetic dianhydride (3,5,6-tricarboxynorbornane-2-acetic dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, tetracyclo [6.2.1 1 , 3 .0 2,7 ] dodecane-4,5,9,10-tetracarboxylic dianhydride, 3, 4-Dicarboxyl-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, 1,3,3a, 4,5,9b-hexahydro-5 (tetrahydro-2,5-dimeric Oxy-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione (1,3,3a, 4,5,9b-hexahydro-5- (tetrahydro-2,5 -dioxo-3-furanyl) -napht ho [1,2-c] -furan-1,3-dione), 1,3,3a, 4,5,9b-hexahydro-5-methyl-5 (tetrahydro-2,5-dioxan Yl-3-furyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-5-ethyl-5 (tetra Hydrogen-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro -7-methyl-5 (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a , 4,5,9b-hexahydro-7-ethyl-5 (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3 -Dione, 1,3,3a, 4,5,9b-hexahydro-8-methyl-5 (tetrahydro-2,5-dioxo-3-furyl) -naphtho [1,2 -c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-8-ethyl-5 (tetrahydro-2,5-dioxo-3-furan ) -Naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-5,8-dimethyl-5 (tetrahydro- 2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 5- (2,5-dioxanyltetrahydrofuranyl) -3 -Methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, bicyclo [2.2.2] -oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, bicyclic [3.3.0] -octane-2,4,6,8-tetracarboxylic dianhydride, 3-oxabicyclo [3.2.1] octane-2,4-dione-6-spiro-3 ' -(Tetrahydrofuran-2 ', 5' -Dione) (3-oxabicyclo [3.2.1] -octane-2,4-dione-6-spiro-3 '-(tetrahydrofuran-2', 5'-dione)), pyromellitic dianhydride, 2,3,3 ', 4'-benzophenonetetracarboxylic dianhydride, 3,3', 4,4'-benzophenonetetracarboxylic dianhydride, 2,2 ', 3,3'- Biphenyltetracarboxylic dianhydride, 2,3,3 ', 4-biphenyltetracarboxylic dianhydride, 3,3', 4,4'-biphenyltetracarboxylic dianhydride, 3,3 ', 4, 4'-biphenylphosphonium tetracarboxylic dianhydride, 1,2,5,6-naphthalenetetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7- Naphthalene tetracarboxylic dianhydride, 2,3,6,7-anthracene tetracarboxylic dianhydride, 1,2,5,6-anthracene tetracarboxylic dianhydride, bis (3,4-dicarboxyphenyl) ether di Anhydride, bis (3,4-dicarboxyphenyl) fluorene dianhydride, bis (3,4-dicarboxyphenyl) methane dianhydride, 2,2-bis (3,4-dicarboxyphenyl) propane dianhydride , 1,1,1,3,3,3-hexafluoro-2,2-bis (3,4-dicarboxyphenyl) propane dianhydride, bis (3,4-dicarboxyphenyl) dimethylsilane Dianhydride, bis (3,4-dicarboxyphenyl) diphenylsilane dianhydride, 2,3,4,5-pyridinetetracarboxylic dianhydride, 2,6-bis (3,4-dicarboxyphenyl) ) Pyridine dianhydride, 3,3 ', 4,4'-dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3', 4,4'-tetraphenylsilane tetracarboxylic dianhydride, 1, 2,3,4-furantetracarboxylic dianhydride, 4,4'- Bis (3,4-dicarboxybenzyl) diphenylmethane dianhydride, 4,4'-bis (3,4-dicarboxybenzyl) diphenylethane dianhydride, 4,4'-bis (3,4-dicarboxybenzyl) diphenylpropane dianhydride, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylmethane dianhydride, 4,4'-bis (3 , 4-dicarboxyphenoxy) diphenylethane dianhydride, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylpropane dianhydride, 4,4'-bis (3, 4-dicarboxyphenoxy) diphenylsulfide dianhydride, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylphosphonium dianhydride, 3,3 ', 4,4'- Perfluoropropylene diphthalic acid dianhydride, 3,3 ', 4,4'-perfluoroisopropylidene diphthalic acid dianhydride, bis (phthalic acid) phenylphosphine oxide dianhydride (bis (phthalic acid) phenylphosphine oxide dianhydride), bis (phthalic acid) phenylsulphine oxide dianhydride, p-phenylene-bis (triphenylphthalic acid) dianhydride triphenylphthalic acid) dianhydride), m-phenylene-bis (triphenylphthalic acid) dianhydride, bis (triphenylphthalic acid) -4,4'-diphenyl ether dianhydride, bis (triphenylphthalic acid) Acid) -4,4'-diphenylmethane dianhydride, ethylene glycol-bis (anhydrotrimellitic anhydride) (ethy lene glycol-bis (anhydrotrimellitate)), propylene glycol-bis (anhydrotrimellitate), 1,4-butanediol-bis (anhydrotrimellitate), 1,6-hexanediol-bis (anhydrous Trimellitic anhydride), 1,8-octanediol-bis (anhydrotrimellitic anhydride), 2,2-bis (4-hydroxyphenyl) propane-bis (anhydrotrimellitic anhydride), formula (6-1) to a tetracarboxylic dianhydride compound represented by the formula (6-6), or a combination of the aforementioned compounds. These compounds can be used singly or in combination. Formula (6-1) In formula (6-2), R 41 and R 43 each independently represent a divalent organic group containing an aromatic ring, R 42 and R 44 each independently represent a hydrogen atom or an alkyl group, and R 42 and R 44 each exist in a plural number. Can be the same or different.

這些化合物可一種單獨或混合複數種使用。 式(6-3) 式(6-4) 式(6-5) 式(6-6)These compounds can be used singly or in combination. Formula (6-3) Formula (6-4) Formula (6-5) Formula (6-6)

上述之四羧酸二酐化合物中,較佳為1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐、3,3’,4,4’-聯苯碸四羧酸二酐。Among the above-mentioned tetracarboxylic dianhydride compounds, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, and 2,3 are preferred. , 5-tricarboxycyclopentylacetic dianhydride, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 3,3 ' , 4,4'-biphenylphosphonium tetracarboxylic dianhydride.

本發明之聚合物(B)中所使用的二胺化合物的具體例,與具有馬來醯胺酸基的化合物(A)中所列舉之二胺化合物相同,在此不再贅述。Specific examples of the diamine compound used in the polymer (B) of the present invention are the same as the diamine compounds listed in the compound (A) having a maleic acid group, and will not be repeated here.

發明之聚合物(B)中,聚醯胺酸(B-1)是由四羧酸二酐化合物與二胺化合物經聚縮合反應而得。其中,基於二胺化合物之胺基為1當量,四羧酸二酐化合物的酸酐基為0.2至2當量,較佳為0.8至1.2當量。In the polymer (B) of the invention, the polyamidic acid (B-1) is obtained by a polycondensation reaction of a tetracarboxylic dianhydride compound and a diamine compound. Among them, the amine group based on the diamine compound is 1 equivalent, and the acid anhydride group of the tetracarboxylic dianhydride compound is 0.2 to 2 equivalents, preferably 0.8 to 1.2 equivalents.

聚醯胺酸(B-1)之聚縮合反應中,四羧酸二酐化合物與二胺化合物於有機溶劑中之反應溫度一般為-20~150℃,較佳為0~100℃。其中,有機溶劑只要能溶解反應物與生成物,則無特別限定。有機溶劑的具體例包括但不限於:N-甲基-2-吡咯烷酮、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、二甲基亞碸、γ-丁內酯、四甲基尿素、六甲基磷酸三胺等非質子系極性溶劑;間-甲酚、二甲苯酚、酚、鹵化酚類等酚系溶劑。有機溶劑可以使用單獨一種或者組合多種來使用。In the polycondensation reaction of polyamic acid (B-1), the reaction temperature of the tetracarboxylic dianhydride compound and the diamine compound in an organic solvent is generally -20 to 150 ° C, preferably 0 to 100 ° C. However, the organic solvent is not particularly limited as long as it can dissolve the reactant and the product. Specific examples of the organic solvent include, but are not limited to, N-methyl-2-pyrrolidone, N, N-dimethylacetamidamine, N, N-dimethylformamidine, dimethylsulfine, γ-butane Aprotic polar solvents such as lactone, tetramethyl urea and hexamethyl phosphate triamine; phenol solvents such as m-cresol, xylenol, phenol, and halogenated phenols. The organic solvents may be used singly or in combination.

上述有機溶劑中,在生成之聚合物不析出的範圍內,可併用適量的貧溶劑如:醇類、酮類、酯類、醚類、鹵化烴類、烴類等。貧溶劑的具體例包括但不限於:甲醇、乙醇、異丙醇、環己醇、乙二醇、丙二醇、1,4-丁二醇、三乙二醇、丙酮、甲基乙基酮、甲基異丁基酮、環己酮、醋酸甲酯、醋酸乙酯、醋酸丁酯、草酸二乙酯、丙二酸二乙酯、二乙基醚、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚、乙二醇二甲基醚、乙二醇乙基醚醋酸酯、二乙二醇二甲基醚、四氫呋喃、二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯、鄰-二氯苯、己烷、庚烷、辛烷、苯、甲苯、二甲苯等。貧溶劑可以使用單獨一種或者組合多種來使用。Among the above organic solvents, an appropriate amount of a lean solvent such as alcohols, ketones, esters, ethers, halogenated hydrocarbons, hydrocarbons, etc. may be used in a range where the polymer produced does not precipitate. Specific examples of the lean solvent include, but are not limited to, methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanediol, triethylene glycol, acetone, methyl ethyl ketone, and methyl alcohol. Isobutyl ketone, cyclohexanone, methyl acetate, ethyl acetate, butyl acetate, diethyl oxalate, diethyl malonate, diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl Ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether , Tetrahydrofuran, dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-dichlorobenzene, hexane, heptane, octane, benzene, Toluene, xylene, etc. The lean solvent may be used singly or in combination.

上述所得之聚醯胺酸(B-1)反應溶液倒入大量之貧溶劑中,所得之析出物,經由減壓乾燥該析出物或者是以蒸發器將反應溶液減壓蒸餾,可得聚醯胺酸(B-1)。此外,將聚醯胺酸(B-1)再次溶解於有機溶劑中,然後用貧溶劑使其析出,或者是以蒸發器減壓蒸餾,經由重複進行一次或數次上述之製程,可得精製之聚醯胺酸(B-1)。The obtained polyamic acid (B-1) reaction solution is poured into a large amount of a lean solvent, and the obtained precipitate is dried under reduced pressure or the reaction solution is distilled under reduced pressure using an evaporator to obtain polyfluorene. Amino acid (B-1). In addition, the polyamidic acid (B-1) can be dissolved in an organic solvent again, and then precipitated with a lean solvent, or it can be distilled under reduced pressure in an evaporator, and can be purified by repeating the above-mentioned process once or several times. Polyamic acid (B-1).

本發明之聚合物(B)中,聚醯亞胺(B-2)是將聚醯胺酸(B-1)進一步脫水閉環(醯亞胺化)處理而得。In the polymer (B) of the present invention, the polyfluorene imine (B-2) is obtained by further dehydrating and closing (polyimine) the polyfluorine acid (B-1).

聚醯胺酸(B-1)之醯亞胺化處理方法例如:聚醯胺酸(B-1)溶解於有機溶劑中,在脫水劑及醯亞胺化觸媒的存在下,加熱進行脫水閉環反應。醯亞胺化的溫度一般為40~200℃、較佳為80~150℃。所使用脫水劑之具體例包括但不限於醋酸酐、丙酸酐、三氟醋酸酐等酸酐類化合物,脫水劑之使用量基於聚醯胺酸(B-1)1莫耳,較佳為0.01至20莫耳為佳。醯亞胺化觸媒之具體包括但不限於吡啶、三甲基吡啶、二甲基吡啶、三乙基胺等三級胺,醯亞胺化觸媒之使用量基於脫水劑1莫耳,較佳為0.5至10莫耳。醯亞胺化處理所使用之溶劑具體例如前述聚醯胺酸(B-1)之聚縮合反應中所列舉之溶劑,在此不再贅述。Polyimide (B-1) is treated by amidine imidization. For example, polyamidate (B-1) is dissolved in an organic solvent, and dehydrated by heating in the presence of a dehydrating agent and amidimide catalyst. Closed loop reaction. The temperature of the imidization is generally 40 to 200 ° C, preferably 80 to 150 ° C. Specific examples of the dehydrating agent used include, but are not limited to, acid anhydride compounds such as acetic anhydride, propionic anhydride, and trifluoroacetic anhydride. The amount of the dehydrating agent used is based on 1 mole of polyamic acid (B-1), preferably 0.01 to 20 mol is better. The specific imidization catalyst includes, but is not limited to, tertiary amines such as pyridine, trimethylpyridine, dimethylpyridine, and triethylamine. The usage amount of the imidization catalyst is based on 1 mole of the dehydrating agent. It is preferably 0.5 to 10 moles. Specific examples of the solvent used for the fluorination treatment include the solvents listed in the aforementioned polycondensation reaction of polyamic acid (B-1), and details are not described herein again.

此外,所得之聚醯亞胺(B-2)反應溶液可以如同前述聚醯胺酸(B-1)精製方法之操作,進一步處理而得到精製之聚醯亞胺(B-2)。In addition, the obtained polyimide (B-2) reaction solution can be further processed in the same manner as in the aforementioned polyamidic acid (B-1) purification method to obtain a purified polyimide (B-2).

本發明之聚合物(B)中,聚醯亞胺系嵌段共聚合物(B-3)依據單體之種類,可以列舉例如:聚醯胺酸嵌段共聚合物(B-3-1)、聚醯亞胺嵌段共聚合物(B-3-2)、聚醯胺酸-聚醯亞胺嵌段共聚合物(B-3-3)。聚醯亞胺系嵌段共聚合物(B-3)是將選自聚醯胺酸(B-1)、聚醯亞胺(B-2)、四羧酸二酐化合物或二胺化合物的化合物於有機溶劑中進一步聚縮合反應而得。化合物的選擇例如:2種末端基相異且構造相異之聚醯胺酸(B-1);2種末端基相異且構造相異之聚醯亞胺(B-2);末端基相異且構造相異之聚醯胺酸(B-1)及聚醯亞胺(B-2);聚醯胺酸(B-1)及四羧酸二酐化合物及二胺化合物,其中四羧酸二酐化合物及二胺化合物的至少一種與聚醯胺酸(B-1)縮合反應時所使用之四羧酸二酐化合物及二胺化合物構造相異;聚醯亞胺(B-2)及四羧酸二酐化合物及二胺化合物,其中四羧酸二酐化合物及二胺化合物的至少一種與聚醯亞胺(B-2)縮合反應時所使用之四羧酸二酐化合物及二胺化合物構造相異;聚醯胺酸(B-1)及聚醯亞胺(B-2)及四羧酸二酐化合物及二胺化合物,其中四羧酸二酐化合物及二胺化合物的至少一種與聚醯胺酸(B-1)及聚醯亞胺(B-2)縮合反應時所使用之四羧酸二酐化合物及二胺化合物構造相異;2種構造相異之聚醯胺酸(B-1)及四羧酸二酐化合物及二胺化合物;2種構造相異之聚醯亞胺(B-2)及四羧酸二酐化合物及二胺化合物;2種末端基為酸酐基且構造相異之聚醯胺酸(B-1)及二胺化合物;2種末端基為胺基且構造相異之聚醯胺酸(B-1)及四羧酸二酐化合物;2種末端基為酸酐基且構造相異之聚醯亞胺(B-2)及二胺化合物;2種末端基為胺基且構造相異之聚醯亞胺(B-2)及四羧酸二酐化合物等。Among the polymers (B) of the present invention, the polyfluorene-based block copolymer (B-3) can be exemplified by the polyfluorine-based block copolymer (B-3-1) depending on the type of monomer. ), Polyfluorene imine block copolymer (B-3-2), polyfluorene acid-polyfluorene imine block copolymer (B-3-3). The polyfluorene-based block copolymer (B-3) is selected from polyfluorine (B-1), polyfluorine (B-2), a tetracarboxylic dianhydride compound, or a diamine compound. The compound is obtained by further polycondensation reaction in an organic solvent. Selection of compounds, for example: 2 types of polyimide (B-1) with different terminal groups and different structures; 2 types of polyimide (B-2) with different terminal groups and different structures; terminal group phase Polyammonium acid (B-1) and polyimide (B-2) which are different and different in structure; polyamine acid (B-1) and tetracarboxylic dianhydride compound and diamine compound, of which tetracarboxylic acid At least one of the acid dianhydride compound and the diamine compound is different in the structure of the tetracarboxylic dianhydride compound and the diamine compound used in the condensation reaction of the polyfluorinated acid (B-1); the polyfluorinated imine (B-2) And a tetracarboxylic dianhydride compound and a diamine compound, in which at least one of the tetracarboxylic dianhydride compound and the diamine compound is used in a condensation reaction with polyfluoreneimine (B-2) The structures of amine compounds are different; polyamine (B-1) and polyimide (B-2) and tetracarboxylic dianhydride compounds and diamine compounds, of which at least tetracarboxylic dianhydride compounds and diamine compounds A tetracarboxylic dianhydride compound and a diamine compound used in the condensation reaction with polyamidic acid (B-1) and polyimide (B-2) have different structures; 2 Polyammonium acid (B-1) and tetracarboxylic dianhydride compounds and diamine compounds with different structures; 2 polyimide (B-2) and tetracarboxylic dianhydride compounds and diamines with different structures Compounds; 2 types of polyamines (B-1) and diamine compounds whose terminal groups are acid anhydride groups and different structures; 2 types of polyamines (B-1) whose terminal groups are amine groups and different structures and Tetracarboxylic dianhydride compounds; 2 polyimide (B-2) and diamine compounds whose terminal groups are acid anhydride groups and have different structures; 2 polyimide compounds whose terminal groups are amine groups and have different structures ( B-2) and tetracarboxylic dianhydride compounds.

聚醯亞胺系嵌段共聚合物(B-3)之聚縮合反應中,反應溫度一般為0至200℃,較佳為0至100℃。所使用溶劑之具體例,如前述聚醯胺酸(B-1)之聚縮合反應中所列舉之溶劑,在此不再贅述。In the polycondensation reaction of the polyfluorene imide-based block copolymer (B-3), the reaction temperature is generally 0 to 200 ° C, and preferably 0 to 100 ° C. Specific examples of the solvent to be used are the same as those listed in the aforementioned polycondensation reaction of polyamic acid (B-1), and are not repeated here.

此外,所得之聚醯亞胺系嵌段共聚合物(B-3)反應溶液,可以如同前述聚醯胺酸(B-1)精製方法之操作,進一步處理可得精製之聚醯亞胺系嵌段共聚合物(B-3)。In addition, the obtained polyimide-based block copolymer (B-3) reaction solution can be processed in the same manner as the aforementioned polyamidic acid (B-1) purification method, and further processed to obtain a purified polyimide-based block copolymer. Block copolymer (B-3).

本發明之聚合物(B),根據凝膠滲透色層分析法所測得經聚苯乙烯換算的重量平均分子量為2,000至200,000,較佳為3,000至100,000,更佳為4,000至50,000。The polymer (B) of the present invention has a polystyrene-equivalent weight average molecular weight measured by a gel permeation chromatography method of 2,000 to 200,000, preferably 3,000 to 100,000, and more preferably 4,000 to 50,000.

基於具有馬來醯胺酸基的化合物(A)的使用量為100重量份,聚合物(B)的使用量可為3至100重量份,較佳為10至80重量份,更佳為15至60重量份。當液晶配向膜中含有聚合物(B)時,則由該液晶配向膜所製得之液晶顯示元件具有較佳的長期信賴性。溶劑( C Based on the use amount of the compound (A) having a maleic acid group as 100 parts by weight, the use amount of the polymer (B) may be 3 to 100 parts by weight, preferably 10 to 80 parts by weight, and more preferably 15 To 60 parts by weight. When the polymer (B) is contained in the liquid crystal alignment film, the liquid crystal display element prepared from the liquid crystal alignment film has better long-term reliability. Solvent ( C )

本發明液晶配向劑之溶劑(C),可選自前述具有馬來醯胺酸基的化合物(A)製造過程及聚合物(B)製造過程中所使用之溶劑,在此不再贅述。基於具有馬來醯胺酸基的化合物(A)的使用量為100重量份,溶劑(C)之使用量為500~5,000重量份,較佳為800~4,000重量份,更佳為1,000~3,000重量份。添加劑( D The solvent (C) of the liquid crystal alignment agent of the present invention may be selected from the solvents used in the manufacturing process of the compound (A) and the polymer (B) having the maleic acid amino group described above, and will not be repeated here. The use amount of the compound (A) having a maleic acid group is 100 parts by weight, and the use amount of the solvent (C) is 500 to 5,000 parts by weight, preferably 800 to 4,000 parts by weight, and more preferably 1,000 to 3,000. Parts by weight. Additive ( D )

本發明之液晶配向劑,在不損害所要求目的物性範圍內,可添加含官能性矽烷化合物或者環氧化合物。含官能性矽烷化合物的具體例包括但不限於:3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷(3-ureidopropyltrimethoxysilane)、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙三胺、N-三甲氧基矽烷基丙基三伸乙三胺、10-三甲氧基矽烷基-1,4,7-三吖癸烷、10-三乙氧基矽烷基-1,4,7-三吖癸烷、9-三甲氧基矽烷基-3,6-二吖壬基醋酸酯、9-三乙氧基矽烷基-3,6-二吖壬基醋酸酯、N-苯甲基-3-胺基丙基三甲氧基矽烷、N-苯甲基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三甲氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三乙氧基矽烷,或上述化合物的組合。In the liquid crystal alignment agent of the present invention, a functional silane-containing compound or an epoxy compound may be added within a range that does not impair the required physical properties. Specific examples of functional silane-containing compounds include, but are not limited to, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2-amine Propyltriethoxysilane, N- (2-aminoethyl) -3-aminopropyltrimethoxysilane, N- (2-aminoethyl) -3-aminopropylmethyl Dimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyltrimethoxy Silane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N-trimethoxysilylpropyltriethylenetriamine Amine, 10-trimethoxysilyl-1,4,7-triazine, 10-triethoxysilyl-1,4,7-triazine, 9-trimethoxysilyl-3 , 6-Diazinyl acetate, 9-triethoxysilyl-3,6-diazinyl acetate, N-benzyl-3-aminopropyltrimethoxysilane, N-benzene Methyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltriethoxysilane, N- Bis (ethylene oxide) -3-aminopropyltrimethoxysilane, N-bis (ethylene oxide) -3-aminopropyltriethoxysilane, or a combination thereof.

環氧化合物的具體例包括但不限於:乙二醇二環氧丙基醚、聚乙二醇二環氧丙基醚、丙二醇二環氧丙基醚、三丙二醇二環氧丙基醚、聚丙二醇二環氧丙基醚、新戊二醇二環氧丙基醚、1,6-己二醇二環氧丙基醚、丙三醇二環氧丙基醚、2,2-二溴新戊二醇二環氧丙基醚、1,3,5,6-四環氧丙基-2,4-己二醇、N,N,N’,N’-四環氧丙基-間-二甲苯二胺、1,3-雙(N,N-二環氧丙基胺基甲基)環己烷、N,N,N’,N’-四環氧丙基-4,4’-二胺基二苯基甲烷、3-(N-烯丙基-N-環氧丙基)胺基丙基三甲氧基矽烷、3-(N,N-二環氧丙基)胺基丙基三甲氧基矽烷,或上述化合物的組合。Specific examples of the epoxy compound include, but are not limited to, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, poly Propylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoxin Pentylene glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, N, N, N ', N'-tetraglycidyl-m- Xylene diamine, 1,3-bis (N, N-glycidylaminomethyl) cyclohexane, N, N, N ', N'-tetraglycidyl-4,4'- Diaminodiphenylmethane, 3- (N-allyl-N-epoxypropyl) aminopropyltrimethoxysilane, 3- (N, N-diepoxypropyl) aminopropyl Trimethoxysilane, or a combination of the above.

基於具有馬來醯胺酸基的化合物(A)的使用量為100重量份,添加劑(D)的使用量可為0.5至50重量份,較佳為1至40重量份,更佳為3至30重量份。液晶配向劑之製造方法 Based on the amount of the compound (A) having a maleic acid group being 100 parts by weight, the amount of the additive (D) may be 0.5 to 50 parts by weight, preferably 1 to 40 parts by weight, and more preferably 3 to 30 parts by weight. Manufacturing method of liquid crystal alignment agent

本發明之液晶配向劑包括具有馬來醯胺酸基的化合物(A)以及溶劑(C),並且可進一步添加聚合物(B)或添加劑(D)。液晶配向劑之製造方法是將具有馬來醯胺酸基的化合物(A)、聚合物(B)、添加劑(D)溶解於溶劑(C)中,混合均勻而製成,配向劑之調製溫度一般為0~200℃,較佳為0~100℃。液晶配向膜之形成 The liquid crystal alignment agent of the present invention includes a compound (A) having a maleic acid group and a solvent (C), and a polymer (B) or an additive (D) may be further added. The liquid crystal alignment agent is manufactured by dissolving a compound (A), a polymer (B), and an additive (D) having a maleic acid group in a solvent (C) and mixing them uniformly. It is generally 0 to 200 ° C, and preferably 0 to 100 ° C. Formation of liquid crystal alignment film

液晶配向膜的製造方法,是將前述液晶配向劑塗佈於基板上後,進行脫水閉環及自由基聚合反應而得。A method for manufacturing a liquid crystal alignment film is obtained by applying the liquid crystal alignment agent to a substrate, and then performing dehydration ring closure and radical polymerization reaction.

首先,在設置有透明導電膜的基板的一面上,將本發明之液晶配向劑以輥塗佈法、旋轉塗佈法、印刷法、噴墨法(ink-jet)等方法塗佈於基板上。其中,較佳為印刷法。接著,將塗佈面進行加熱處理使液晶配向劑形成塗膜。First, on one side of a substrate provided with a transparent conductive film, the liquid crystal alignment agent of the present invention is coated on the substrate by a method such as a roll coating method, a spin coating method, a printing method, or an ink-jet method. . Among these, the printing method is preferred. Next, the coating surface is subjected to a heat treatment to form a liquid crystal alignment agent into a coating film.

基板之具體例包括但不限於:無鹼玻璃、鈉鈣玻璃、硬質玻璃(派勒斯玻璃)、石英玻璃等的玻璃;聚乙烯對苯二甲酸酯、聚丁烯對苯二甲酸酯、聚醚碸、聚碳酸酯等的塑膠透明基板。Specific examples of the substrate include, but are not limited to, glass such as alkali-free glass, soda lime glass, hard glass (Pales glass), quartz glass, etc .; polyethylene terephthalate, polybutene terephthalate Plastic transparent substrates such as polyether, polycarbonate, polycarbonate, etc.

形成液晶配向膜之加熱處理包含液晶配向劑塗佈後之預烤處理(pre-bake),預烤處理可使有機溶劑揮發形成塗膜,加熱處理溫度一般為30至150℃、較佳為50至120℃、更佳為60至100℃。預烤處理可於0.1分鐘至30分鐘的任意時間內進行,較佳為進行0.5分鐘至15分鐘,更佳為進行1分鐘至5分鐘。The heat treatment for forming the liquid crystal alignment film includes a pre-bake treatment after the application of the liquid crystal alignment agent. The pre-bake treatment can volatilize the organic solvent to form a coating film. The heat treatment temperature is generally 30 to 150 ° C, preferably 50. To 120 ° C, more preferably 60 to 100 ° C. The pre-baking treatment may be performed at any time from 0.1 minutes to 30 minutes, preferably from 0.5 minutes to 15 minutes, and more preferably from 1 minute to 5 minutes.

在塗膜形成後,再進一步進行後烤處理(post-bake),使脫水閉環(醯亞胺化)及自由基聚合反應同時進行而形成醯亞胺化之配向膜塗膜。後烤處理溫度一般為100至350℃,較佳為120至280℃,更佳為150至250℃。後烤處理可於5分鐘至240分鐘的任意時間內進行,較佳為進行10分鐘至100分鐘,更佳為進行20分鐘至90分鐘。上述加熱可藉由一般公知方法,例如可以加熱板、熱風循環爐或紅外線爐進行加熱。After the coating film is formed, a post-bake process is further performed to simultaneously perform dehydration ring closure (fluorene imidization) and radical polymerization reaction to form a fluorinated alignment film coating film. The post-baking treatment temperature is generally 100 to 350 ° C, preferably 120 to 280 ° C, and more preferably 150 to 250 ° C. The post-baking treatment may be performed at any time from 5 minutes to 240 minutes, preferably 10 minutes to 100 minutes, and more preferably 20 minutes to 90 minutes. The heating can be performed by a generally known method, for example, a heating plate, a hot-air circulation furnace, or an infrared furnace can be used for heating.

本發明在形成液晶配向膜之處理中,亦可先進行紫外線照射,再進行後加熱處理。液晶配向劑中亦可依需要添加光聚合起始劑或熱聚合起始劑。In the process of forming a liquid crystal alignment film according to the present invention, ultraviolet irradiation may be performed first, and then post-heating treatment may be performed. A liquid polymerization initiator or a thermal polymerization initiator may be added to the liquid crystal alignment agent as required.

其中,脫水閉環(醯亞胺化)反應是將馬來醯胺酸基經醯亞胺化,形成馬來醯亞胺基,該反應之具體例如反應式(1)所示:反應式(1)Among them, the dehydration ring-closing (fluorene imidization) reaction is a process in which maleimide amino acid group is imidized to form a maleimide group. A specific example of the reaction is shown in reaction formula (1): Reaction Formula (1)

而自由基聚合反應則是將含有C=C雙鍵之化合物,例如含馬來醯亞胺基化合物進行聚合反應,形成架橋型結構。並且,自由基聚合反應發生在具有馬來醯胺酸基的化合物(A)經脫水閉環反應後生成的雙鍵上。該反應之具體例如反應式(2)所示:反應式(2)In the free radical polymerization, a compound containing a C = C double bond, such as a maleimide-containing imino group, is polymerized to form a bridge structure. In addition, the radical polymerization reaction occurs on the double bond generated after the dehydration ring-closing reaction of the compound (A) having a maleic acid group. A specific example of this reaction is shown in Reaction Formula (2): Reaction formula (2)

經脫水閉環(醯亞胺化)及自由基聚合反應所得醯亞胺化配向膜之具體例,如下式表示之具架橋結構之配向膜。 液晶顯示元件的製造方法 Specific examples of the fluorene imidized alignment film obtained through dehydration ring closure (fluorene imidization) and radical polymerization reaction are alignment films with a bridge structure represented by the following formula. Manufacturing method of liquid crystal display element

本發明之液晶顯示元件,可以依據下記方法製造而得。The liquid crystal display element of the present invention can be manufactured by the following method.

首先,分別於包含導電膜的一對基板上形成如上所述的液晶配向膜,將形成有所述液晶配向膜的所述基板以所述液晶配向膜對向的方式配置,並於所述基板之間注入液晶組成物而形成液晶胞,接著於所述導電膜間施加電壓,並於施加電壓狀態下用光照射所述液晶胞。最後,在液晶胞的外側表面貼合偏光板,可以得到本發明的液晶顯示元件。其中,作為使用的基板與前述形成液晶配向膜中所使用的基板相同,在此不再贅述。First, the above-mentioned liquid crystal alignment film is formed on a pair of substrates including a conductive film, and the substrate on which the liquid crystal alignment film is formed is arranged in such a manner that the liquid crystal alignment film faces each other, and is placed on the substrate. A liquid crystal composition is injected therebetween to form a liquid crystal cell, and then a voltage is applied between the conductive films, and the liquid crystal cell is irradiated with light under a voltage application state. Finally, a polarizing plate is bonded to the outer surface of the liquid crystal cell to obtain a liquid crystal display element of the present invention. The substrate used is the same as the substrate used in the formation of the liquid crystal alignment film, and is not repeated here.

作為上述導電膜,較佳為使用透明導電膜,例如由SnO2 形成的NESA膜、由In2 O3 -SnO2 形成的ITO膜等。該導電膜較佳為各別區分為多個區域的圖案狀導電膜。當形成該種導電膜結構,在導電膜間施加電壓時,藉由對每個區域施加不同的電壓,可以改變每個區域的液晶分子的預傾角方向,藉此可以將視角性質進一步提升。As the conductive film, a transparent conductive film such as a NESA film made of SnO 2 or an ITO film made of In 2 O 3 -SnO 2 is preferably used. The conductive film is preferably a patterned conductive film which is divided into a plurality of regions. When such a conductive film structure is formed, when a voltage is applied between the conductive films, by applying different voltages to each region, the pretilt direction of the liquid crystal molecules in each region can be changed, thereby further improving the viewing angle property.

製造液晶胞可以列舉出例如下述2種方法。The liquid crystal cell can be produced by, for example, the following two methods.

第一種方法是目前習知的方法。首先,將2塊基板隔著間隙(胞間隙)對向配置,使各自的液晶配向膜相對向,使用密封劑,將2塊基板的周邊部位貼合在一起,在由基板表面和密封劑劃分的胞間隙內注入填充液晶後,密封注入孔,可以製造液晶胞。The first method is currently known. First, the two substrates are arranged to face each other with a gap (cell gap) therebetween, and the respective liquid crystal alignment films are opposed to each other. Using a sealant, the peripheral parts of the two substrates are bonded together, and divided by the substrate surface and the sealant. After filling and filling the liquid crystal in the intercellular space, the injection hole is sealed, and a liquid crystal cell can be manufactured.

第二種方法是稱作ODF(One Drop Fill)方式的方法。在形成液晶配向膜的2塊基板中的一塊基板上的規定位置,塗布例如紫外光硬化性密封材料,然後在液晶配向膜面上滴加液晶後,貼合另一塊基板使液晶配向膜對向,接著,對基板整面照射紫外光,使密封劑硬化,製造液晶胞。The second method is a method called an ODF (One Drop Fill) method. Apply a UV-curable sealing material to a predetermined position on one of the two substrates forming the liquid crystal alignment film, and then drop the liquid crystal on the liquid crystal alignment film surface. Then, attach the other substrate so that the liquid crystal alignment film faces the liquid crystal alignment film. Next, the entire surface of the substrate is irradiated with ultraviolet light to harden the sealant to produce a liquid crystal cell.

其中,作為密封劑,可以列舉出例如含有硬化劑和作為間隔物(spacer)的氧化鋁球的環氧樹脂等。Among them, examples of the sealant include epoxy resin containing a hardener and alumina balls as a spacer.

作為前述液晶組成物,可於具有負的介電異方性的向列型液晶,例如二氰基苯類液晶、噠嗪類液晶、希夫鹼類液晶、氧化偶氮基類液晶、聯苯類液晶、苯基環己烷類液晶等液晶中添加聚合性化合物,該聚合性化合物可使用一般公知的化合物,在種類上並無特別的限制,例如具有丙烯醯基與液晶骨格之化合物。另外,亦可併用聚合性化合物與聚合起始劑添加於液晶中。上述聚合性化合物的添加量一般為0.1wt%至1wt%。The liquid crystal composition may be a nematic liquid crystal having negative dielectric anisotropy, such as a dicyanobenzene-based liquid crystal, a pyridazine-based liquid crystal, a Schiff base-based liquid crystal, an azo-based liquid crystal, and biphenyl. Polymerizable compounds are added to liquid crystals such as liquid crystals such as phenylcyclohexane, and liquid crystals such as phenylcyclohexane-based liquid crystals. Generally known compounds can be used as the polymerizable compound, and there is no particular limitation on the type, for example, a compound having an acrylyl group and a liquid crystal skeleton. In addition, a polymerizable compound and a polymerization initiator may be added to the liquid crystal in combination. The addition amount of the polymerizable compound is generally 0.1 wt% to 1 wt%.

作為施加的電壓例如可以是5 V至50 V的直流電或交流電。The voltage to be applied may be, for example, a direct current or an alternating current of 5 V to 50 V.

作為照射的光,可以使用例如包含150至800 nm波長光的紫外線和可見光,較佳為包含300至400 nm波長光的紫外線。作為照射光的光源,可以使用例如低壓水銀燈、高壓水銀燈、重氫燈、金屬鹵化物燈、氬共振燈、氙燈、準分子鐳射等。前述較佳的波長區域的紫外線可以通過將前述光源和例如濾色片、衍射光柵等併用的方法等而得到。As the light to be irradiated, for example, ultraviolet rays including visible light with a wavelength of 150 to 800 nm and visible light may be used, and ultraviolet rays including light with a wavelength of 300 to 400 nm can be preferably used. As a light source for irradiating light, for example, a low-pressure mercury lamp, a high-pressure mercury lamp, a heavy hydrogen lamp, a metal halide lamp, an argon resonance lamp, a xenon lamp, an excimer laser, or the like can be used. The ultraviolet rays in the aforementioned preferable wavelength region can be obtained by a method in which the aforementioned light source is used in combination with, for example, a color filter and a diffraction grating.

作為光的照射量,較佳為1,000 J/m2 以上且小於100,000 J/m2 ,更佳為1,000至50,000 J/m2 。製造以往已知的PSA模式的液晶顯示元件時,需要100,000 J/m2 程度的光照射量。然,在本發明的方法中,即使光照射量為50,000 J/m2 以下,進一步為10,000 J/m2 以下時,也可以得到良好的液晶顯示元件,從而有助於減低液晶顯示元件的製造成本。As the light irradiation amount, preferably 1,000 J / m 2 or more and less than 100,000 J / m 2, more preferably 1,000 to 50,000 J / m 2. When manufacturing a conventionally known PSA mode liquid crystal display element, a light irradiation amount of about 100,000 J / m 2 is required. However, in the method of the present invention, even when the light irradiation amount is 50,000 J / m 2 or less, and further 10,000 J / m 2 or less, a good liquid crystal display element can be obtained, thereby contributing to reducing the manufacturing of the liquid crystal display element. cost.

作為貼合到液晶胞外表面的偏光板,可以列舉用醋酸纖維素保護膜夾住使聚乙烯醇拉伸配向同時吸收碘所得的稱作「H膜」的偏光膜形成的偏光板或由H膜本身形成的偏光板。Examples of the polarizing plate attached to the outer surface of the liquid crystal include a polarizing plate formed of a polarizing film called "H film" obtained by sandwiching polyvinyl alcohol with a protective film of cellulose acetate and stretching and aligning while absorbing iodine. The film itself forms a polarizing plate.

本發明將就以下實施例來作進一步說明,但應瞭解的是,該等實施例僅為例示說明,而不應被解釋為本發明實施的限制。具有馬來醯胺酸基的化合物( A )的合成例 The present invention will be further described with reference to the following examples, but it should be understood that these examples are merely illustrative and should not be construed as limitations of the implementation of the present invention. Synthesis example of the compound ( A ) having a maleic acid group

以下說明具有馬來醯胺酸基的化合物(A)的合成例A-1至合成例A-12:合成例 A-1 The following describes Synthesis Example A-1 to Synthesis Example A-12 of Compound (A) having a maleamic acid group: Synthesis Example A-1

在容積500毫升的四頸燒瓶上設置氮氣入口、攪拌器、加熱器、冷凝管及溫度計,並導入氮氣。然後,在四頸燒瓶中,加入3.95克(0.015莫耳)的二胺化合物Da1(簡稱為a2-1-1)、2.82克(0.0075莫耳)的1-十八烷氧基-2,4-二胺基苯(簡稱為a2-2-1)以及50克的四氫呋喃(以下簡稱THF),並於室溫下攪拌至溶解。接著,加入2.81克(0.025莫耳)的2-甲基馬來酸酐(簡稱為a1-1),於室溫下反應3小時,反應結束後,將反應溶液過濾,再將過濾所得之固體重複以THF清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,即可得具有馬來醯胺酸基的化合物(A-1)。合成例 A-2 至合成例 A-12 與比較合成例 A-13 至比較合成例 A-15 A 500 ml four-necked flask was provided with a nitrogen inlet, a stirrer, a heater, a condenser, and a thermometer, and nitrogen was introduced. Then, in a four-necked flask, 3.95 g (0.015 mol) of the diamine compound Da1 (abbreviated as a2-1-1) and 2.82 g (0.0075 mol) of 1-octadecyloxy-2,4 were added. -Diaminobenzene (abbreviated as a2-2-1) and 50 g of tetrahydrofuran (hereinafter abbreviated as THF), and stirred at room temperature until dissolved. Next, 2.81 g (0.025 mole) of 2-methylmaleic anhydride (abbreviated as a1-1) was added, and the reaction was performed at room temperature for 3 hours. After the reaction was completed, the reaction solution was filtered, and the filtered solid was repeated After being washed and filtered three times with THF, put into a vacuum oven and dried at a temperature of 60 ° C., a compound (A-1) having a maleic acid group can be obtained. Synthesis Example A-2 to Synthesis Example A-12 and Comparative Synthesis Example A-13 to Comparative Synthesis Example A-15

合成例A-2至合成例A-12與比較合成例A-13至比較合成例A-15是以與合成例A-1相同的步驟來分別製備具有馬來醯胺酸基的化合物(A-2)至具有馬來醯胺酸基的化合物(A-15),並且其不同處在於:改變單體的種類及其使用量(如表1所示)。Synthesis Example A-2 to Synthesis Example A-12 and Comparative Synthesis Example A-13 to Comparative Synthesis Example A-15 were prepared in the same procedure as Synthesis Example A-1, respectively, to prepare a compound having a maleic acid group (A -2) to the compound (A-15) having a maleic acid amino group, and the difference lies in that the type of the monomer and its usage amount are changed (as shown in Table 1).

表1中簡稱所對應的化合物如下所示。 The compounds corresponding to the abbreviations in Table 1 are shown below.

[表1] 聚合物( B )的合成例 [Table 1] Polymer (B) Synthesis Example

以下說明聚合物(B)的合成例B-1至合成例B-3:合成例 B-1 Synthesis Example B-1 to Synthesis Example B-3 of Polymer (B) will be described below: Synthesis Example B-1

在容積500毫升的四頸燒瓶上設置氮氣入口、攪拌器、加熱器、冷凝管及溫度計,並導入氮氣。然後,在四頸燒瓶中,加入20.0克(0.1莫耳)的4,4’-二胺基二苯基醚,以及180克的N-甲基吡咯烷酮(以下簡稱為NMP),於室溫下攪拌至溶解。再加入10.9克(0.05莫耳)的苯均四羧酸二酐、9.8克(0.05莫耳)的環丁烷四羧酸二酐以及50克的NMP,於室溫下反應6小時,反應結束後,將反應液倒入1500毫升水中將聚合物析出,過濾所得之聚合物重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,即可得聚合物(B-1)。合成例 B-2 A 500 ml four-necked flask was provided with a nitrogen inlet, a stirrer, a heater, a condenser, and a thermometer, and nitrogen was introduced. Then, in a four-necked flask, 20.0 g (0.1 mol) of 4,4'-diaminodiphenyl ether and 180 g of N-methylpyrrolidone (hereinafter referred to as NMP) were added at room temperature. Stir until dissolved. Add 10.9 g (0.05 mol) of pyromellitic dianhydride, 9.8 g (0.05 mol) of cyclobutane tetracarboxylic dianhydride, and 50 g of NMP, and react at room temperature for 6 hours. The reaction is complete. Then, the reaction solution was poured into 1500 ml of water to precipitate the polymer. The polymer obtained by filtration was repeatedly washed with methanol and filtered three times, placed in a vacuum oven, and dried at a temperature of 60 ° C to obtain a polymer (B- 1). Synthesis Example B-2

在容積500毫升的四頸燒瓶上設置氮氣入口、攪拌器、加熱器、冷凝管及溫度計,並導入氮氣。然後,在四頸燒瓶中,加入10.8克(0.1莫耳)的對-二胺苯,以及100克的NMP,於室溫下攪拌至溶解。再加入33.0克(0.11莫耳)的3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐以及60克的NMP,於室溫下反應6小時,反應結束後,加入97克的NMP、2.55克的醋酸酐及19.75克的吡啶,升溫至60℃,且持續攪拌2小時,以進行醯亞胺化反應。反應結束後,將反應液倒入1500毫升水中將聚合物析出,過濾所得之聚合物重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,即可得聚合物(B-2)。合成例 B-3 A 500 ml four-necked flask was provided with a nitrogen inlet, a stirrer, a heater, a condenser, and a thermometer, and nitrogen was introduced. Then, in a four-necked flask, 10.8 g (0.1 mol) of p-diaminebenzene and 100 g of NMP were added and stirred at room temperature until dissolved. Add 33.0 g (0.11 mole) of 3,4-dicarboxyl-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride and 60 g of NMP, and react at room temperature for 6 hours. After the end, 97 g of NMP, 2.55 g of acetic anhydride, and 19.75 g of pyridine were added, the temperature was raised to 60 ° C., and stirring was continued for 2 hours to perform the amidine imidization reaction. After the reaction is complete, the reaction solution is poured into 1500 ml of water to precipitate the polymer. The polymer obtained by filtration is repeatedly washed with methanol and filtered three times, placed in a vacuum oven, and dried at a temperature of 60 ° C. B-2). Synthesis Example B-3

在容積500毫升的四頸燒瓶上設置氮氣入口、攪拌器、加熱器、冷凝管及溫度計,並導入氮氣。然後,在四頸燒瓶中,加入3克的合成例B-1所得之聚合物(B-1)、17克的NMP,於室溫下攪拌至溶解。再加入3克的合成例B-2所得之聚合物(B-2)與17克的NMP,於60℃下反應6小時,反應結束後,將反應液倒入1500毫升水中將聚合物析出,過濾所得之聚合物重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,即可得聚合物(B-3)。液晶配向劑、液晶配向膜以及液晶顯示元件 的實施例與比較例 A 500 ml four-necked flask was provided with a nitrogen inlet, a stirrer, a heater, a condenser, and a thermometer, and nitrogen was introduced. Then, in a four-necked flask, 3 g of the polymer (B-1) obtained in Synthesis Example B-1 and 17 g of NMP were added and stirred at room temperature until dissolved. Then, 3 g of the polymer (B-2) obtained in Synthesis Example B-2 and 17 g of NMP were added and reacted at 60 ° C for 6 hours. After the reaction was completed, the reaction solution was poured into 1500 ml of water to precipitate the polymer. The polymer obtained by filtration was repeatedly washed with methanol and filtered three times, placed in a vacuum oven, and dried at a temperature of 60 ° C to obtain a polymer (B-3). The liquid crystal alignment agent, the liquid crystal with embodiment examples and comparative examples to a display element and a liquid crystal film

以下說明液晶配向劑、液晶配向膜以及液晶顯示元件的實施例1至實施例15以及比較例1至比較例5。實施例 1 a. 液晶配向劑 Hereinafter, Examples 1 to 15 and Comparative Examples 1 to 5 of the liquid crystal alignment agent, the liquid crystal alignment film, and the liquid crystal display element will be described. Example 1 a. Liquid crystal alignment agent

將合成例1中所得之具有馬來醯胺酸基的化合物(A-1)100重量份溶於2000重量份的N-甲基-2-吡咯烷酮(C-1)與1000重量份的乙二醇正丁基醚(C-2)中,於室溫下以攪拌裝置持續攪拌至完全溶解,即可形成實施例1的液晶配向劑。b. 液晶配向膜及液晶顯示元件 100 parts by weight of the compound having a maleic acid group (A-1) obtained in Synthesis Example 1 was dissolved in 2000 parts by weight of N-methyl-2-pyrrolidone (C-1) and 1,000 parts by weight of ethylenediamine. In the alcohol n-butyl ether (C-2), the liquid crystal alignment agent of Example 1 can be formed by continuously stirring until completely dissolved with a stirring device at room temperature. b. Liquid crystal alignment film and liquid crystal display element

使用上述所得的液晶配向劑,以下述所示的順序製作液晶顯示元件。首先,將液晶配向劑以旋轉塗佈的方式,分別塗佈於兩片具有ITO電極的玻璃基板上,其中,該ITO電極為線/間距(Line/Space)各自為5μm的狹縫狀(slit)圖案。之後於加熱板上,以溫度80℃、時間2分鐘進行預烤,以及在循環烘箱中,以溫度230℃、時間15分鐘進行後烤,即可形成實施例1的液晶配向膜。Using the obtained liquid crystal alignment agent, a liquid crystal display element was produced in the procedure shown below. First, the liquid crystal alignment agent was spin-coated on two glass substrates each having an ITO electrode, where the ITO electrodes were slits with a line / space of 5 μm each. )pattern. Thereafter, pre-baking is performed on a hot plate at a temperature of 80 ° C. for 2 minutes, and in a circulating oven, post-baking is performed at a temperature of 230 ° C. for 15 minutes to form a liquid crystal alignment film of Example 1.

對於以上述步驟所製得之兩片形成有液晶配向膜的玻璃基板,其中一片玻璃基板塗以熱壓膠,另一片玻璃基板灑上4μm的間隔物(spacer),接著,將兩片玻璃基板進行貼合,再以熱壓機施以10kg的壓力,在溫度為150℃的條件下進行熱壓貼合。然後,以液晶注入機(島津製作所製造,型號為ALIS-100X-CH)注入負介電異方性的液晶(Merck製造,型號為MLC 6883),其中,液晶中添加0.1wt%的4,4’-亞聯苯基二甲基丙烯酸酯(4,4'-biphenylene methacrylate)作為聚合性化合物,再利用紫外光硬化膠封住液晶注入口,並以紫外光燈照光使其硬化。接著,於兩個ITO電極之間施加20V交流電,並在液晶為驅動狀態下照射30J的紫外線後,即可獲得實施例1的液晶顯示元件。將實施例1的液晶顯示元件以下記之各測定評價方式進行評價,所得結果如表2所示。實施例 2 至實施例 15 及比較例 1 至比較例 3 For the two glass substrates formed with the liquid crystal alignment film prepared in the above steps, one of the glass substrates was coated with hot-press adhesive, and the other glass substrate was coated with a 4 μm spacer, and then, the two glass substrates were coated with a spacer. The bonding was performed, and then a pressure of 10 kg was applied with a hot press, and the hot-press bonding was performed at a temperature of 150 ° C. Then, a liquid crystal injection machine (manufactured by Shimadzu Corporation, model: ALIS-100X-CH) was used to inject negative dielectric anisotropic liquid crystal (Merck, model: MLC 6883), in which 0.1% by weight of 4,4 was added to the liquid crystal. '4'-biphenylene methacrylate (4,4'-biphenylene methacrylate) is used as a polymerizable compound, and then the liquid crystal injection port is sealed with an ultraviolet curing adhesive, and then cured by ultraviolet light. Next, after applying an alternating current of 20 V between the two ITO electrodes and irradiating 30 J of ultraviolet rays while the liquid crystal is in a driving state, the liquid crystal display element of Example 1 can be obtained. The liquid crystal display element of Example 1 was evaluated by each measurement evaluation method described below, and the results are shown in Table 2. Examples 2 to 15 and Comparative Examples 1 to 3

實施例2至實施例15及比較例1至比較例3的液晶配向劑、液晶配向膜及液晶顯示元件是以與實施例1相同的步驟分別製備,並且其不同處在於:改變成分的種類及其使用量,如表3所示。將實施例2至實施例15及比較例1至比較例3所製得之液晶顯示元件以後述評價方式進行評價,其結果如表2所示。The liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element of Examples 2 to 15 and Comparative Examples 1 to 3 were prepared by the same steps as in Example 1, and the difference was that the type and The amount used is shown in Table 3. The liquid crystal display elements prepared in Examples 2 to 15 and Comparative Examples 1 to 3 were evaluated by the evaluation method described later. The results are shown in Table 2.

表2中簡稱所對應的化合物如下所示。 評價方式 a. 聚合性化合物殘留 The compounds corresponding to the abbreviations in Table 2 are shown below. < Evaluation method > a. Residual of polymerizable compound

對實施例及比較例的液晶顯示元件之電極間施加頻率60赫茲的10伏特交流電壓,在液晶屬於驅動之狀態下,照射100,000 J/m2 的紫外光(紫外光照射機型號為 KN-SH48K1;光能興業製造)。接著,取出液晶層,根據高效液相層析法(High Performance Liquid Chromatography,簡稱HPLC)量測聚合性化合物的殘留量(γ)。A 10-volt AC voltage having a frequency of 60 Hz was applied between the electrodes of the liquid crystal display elements of the examples and comparative examples, and the liquid crystal was driven, and 100,000 J / m 2 of ultraviolet light was irradiated. ; Solar Energy Industrial Manufacturing). Next, the liquid crystal layer was taken out, and the residual amount (γ) of the polymerizable compound was measured by High Performance Liquid Chromatography (HPLC).

聚合性化合物殘留的評價基準如下所示。 ◎:γ<500ppm ○:500ppm≦γ<800ppm △:800ppm≦γ<1000ppm ╳:γ≧1000ppmb. 長期信賴性 The evaluation criteria of the polymerizable compound residue are shown below. ◎: γ <500ppm ○: 500ppm ≦ γ <800ppm △: 800ppm ≦ γ <1000ppm ╳: γ ≧ 1000ppm b. Long-term reliability

對實施例及比較例的液晶顯示元件之電極間施加頻率60赫茲的10伏特交流電壓,在液晶屬於驅動之狀態下,照射30,000 J/m2 的紫外光(紫外光照射機型號為KN-SH48K1;光能興業製造)。接著,以「T.J.Scheffer, et.al., J.Appl.Phys., vol.19, 2013 (1980)」記載的方法為準,使用液晶評價裝置(中央精機製,型號OMS-CM4RD)透過He-Ne雷射光之結晶旋轉法,量測該液晶顯示元件之中心點,可測得第一預傾角(P1)。然後,將液晶顯示元件置於60℃的烘箱中靜置200小時後,量測上述相同位置,可得第二預傾角(P2)。最後,透過以下公式計算出長期信賴性R: R(°) =│P1-P2│ 數學式(1)Applying an alternating voltage 10 volts 60 hertz frequency component between the electrodes, the liquid crystal in a state belonging to the drive, the irradiated ultraviolet 30,000 J / m 2 (the UV irradiation machine Model KN-SH48K1 embodiment of the liquid crystal display of the examples and comparative examples ; Solar Energy Industrial Manufacturing). Next, using the method described in "TJScheffer, et.al., J. Appl. Phys., Vol. 19, 2013 (1980)", a liquid crystal evaluation device (central precision mechanism, model OMS-CM4RD) was passed through He- Ne laser light crystal rotation method, measuring the center point of the liquid crystal display element, can measure the first pretilt angle (P1). Then, after the liquid crystal display element was placed in an oven at 60 ° C. for 200 hours, the same position as described above was measured to obtain a second pretilt angle (P2). Finally, the long-term reliability R is calculated by the following formula: R (°) = │P1-P2│ Mathematical formula (1)

長期信賴性的評價基準如下所示。 ◎:R<1.0 ○:1.0≦R <1.5 △:1.5≦R<2.0 ╳:R≧2.0The evaluation criteria for long-term reliability are shown below. ◎: R <1.0 ○: 1.0 ≦ R <1.5 △: 1.5 ≦ R <2.0 ╳: R ≧ 2.0

[表2] 評價結果 [Table 2] Evaluation results

由表2得知,與具有由式(1)表示的架橋結構的液晶配向膜所製得的液晶顯示元件(實施例1至實施例15)相比,不具有由式(1)表示的架橋結構的液晶顯示元件(比較例1至比較例5)有聚合性化合物殘留的問題。As can be seen from Table 2, compared with a liquid crystal display element (Example 1 to Example 15) made of a liquid crystal alignment film having a bridge structure represented by Formula (1), it does not have a bridge represented by Formula (1) A liquid crystal display element having a structure (Comparative Examples 1 to 5) has a problem that a polymerizable compound remains.

另外,當基於二胺組份(a2)的總使用量為100莫耳,二胺化合物(a2-1)的使用量為5至70莫耳時(實施例1至實施例7、實施例9至實施例11、實施例13至實施例15),可得到液晶層中殘留的未反應的聚合性化合物更少的液晶顯示元件。In addition, when the total amount of use based on the diamine component (a2) is 100 mol, and the amount of use of the diamine compound (a2-1) is 5 to 70 mol (Examples 1 to 7, and Example 9) Up to Example 11 and Examples 13 to 15), a liquid crystal display device having less unreacted polymerizable compounds remaining in the liquid crystal layer can be obtained.

又,當二胺組份(a2)包含由式(3)表示的二胺化合物(a2-2)時(實施例1、實施例2、實施例4、實施例6至實施例9、實施例12及實施例13),液晶顯示元件的長期信賴性更佳。When the diamine component (a2) contains the diamine compound (a2-2) represented by the formula (3) (Example 1, Example 2, Example 4, Example 6 to Example 9, Example 12 and Example 13), the long-term reliability of the liquid crystal display element is better.

此外,當液晶配向膜中含有聚合物(B)時(實施例5、實施例9、實施例11及實施例14),液晶顯示元件的長期信賴性更佳。In addition, when the polymer (B) is contained in the liquid crystal alignment film (Example 5, Example 9, Example 11 and Example 14), the long-term reliability of the liquid crystal display element is better.

綜上所述,本發明的液晶配向膜中包含特定的架橋結構,因此不會有液晶層中殘留未反應化合物的問題。進一步而言,本發明的液晶配向膜由於包含含有光反應性基的有機基團的架橋結構,而使液晶層中不殘留未反應化合物,並且沒有長期信賴性不佳之問題,因此適用於製造液晶配向膜及液晶顯示元件。In summary, the liquid crystal alignment film of the present invention includes a specific bridge structure, so there is no problem that unreacted compounds remain in the liquid crystal layer. Furthermore, since the liquid crystal alignment film of the present invention contains a bridging structure of an organic group containing a photoreactive group, there is no unreacted compound remaining in the liquid crystal layer, and there is no problem of poor long-term reliability, so it is suitable for manufacturing liquid crystals. Alignment film and liquid crystal display element.

雖然本發明已以實施例揭露如上,然其並非用以限定本發明,任何所屬技術領域中具有通常知識者,在不脫離本發明的精神和範圍內,當可作些許的更動與潤飾,故本發明的保護範圍當視後附的申請專利範圍所界定者為準。Although the present invention has been disclosed as above with the examples, it is not intended to limit the present invention. Any person with ordinary knowledge in the technical field can make some modifications and retouching without departing from the spirit and scope of the present invention. The protection scope of the present invention shall be determined by the scope of the attached patent application.

無。no.

無。no.

Claims (8)

一種液晶配向膜,包括由式(1)表示的架橋結構:式(1)中,T表示脂肪族系或芳香族系的結構;Q表示含有光反應性基的有機基團;k表示1以上的整數,其中所述架橋結構由具有馬來醯胺酸基的化合物(A)經自由基聚合反應而得,所述具有馬來醯胺酸基的化合物(A)於一分子中具有2個或2個以上可聚合性的馬來醯胺酸基,所述具有馬來醯胺酸基的化合物(A)由馬來酸酐衍生物(a1)及二胺組份(a2)反應而得,其中所述光反應性基包括乙烯基、(甲基)丙烯酸基、蒽基、桂皮酸基、查耳酮基、香豆基、馬來醯亞胺基或二苯乙烯基中的至少一者。A liquid crystal alignment film includes a bridge structure represented by formula (1): In formula (1), T represents an aliphatic or aromatic structure; Q represents an organic group containing a photoreactive group; and k represents an integer of 1 or more, wherein the bridging structure consists of a maleic acid group The compound (A) is obtained by a radical polymerization reaction, and the compound (A) having a maleic acid amino group has 2 or more polymerizable maleic acid amino groups in one molecule. The compound (A) having a maleic acid amino group is obtained by reacting a maleic anhydride derivative (a1) and a diamine component (a2), wherein the photoreactive group includes vinyl, (meth) acrylic acid At least one of an alkyl group, an anthryl group, a cinnamic acid group, a chalcone group, a coumarin group, a maleimide group, or a stilbyl group. 如申請專利範圍第1項所述的液晶配向膜,其中,所述自由基聚合反應發生在所述具有馬來醯胺酸基的化合物(A)經脫水閉環反應後生成的雙鍵上。The liquid crystal alignment film according to item 1 of the scope of the patent application, wherein the radical polymerization reaction occurs on a double bond generated after the compound (A) having a maleic acid amino group undergoes a dehydration ring-closing reaction. 如申請專利範圍第1項所述的液晶配向膜,其中所述二胺組份(a2)包含由式(2)表示的二胺化合物(a2-1):式(2)中,Ra表示-CH2-、-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-;Rb表示碳數為1至20的未經取代或經氟原子取代的直鏈狀伸烷基,且所述伸烷基中任意的-CH2-可經-CF2-、-CH=CH-或下述的取代基取代,所述取代基包括:-O-、-COO-、-NHCO-、-NH-、碳環基或雜環基,其中,當兩個以上的-CH2-經所述取代基取代時,所述取代基不相鄰接;Rc表示-CH2-、-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-COO-、-OCO-、-CON(CH3)-、-N(CH3)CO-、碳環基或雜環基;Rd表示乙烯苯基、-CRe=CH2、碳環基、雜環基、或由下述結構式表示的基團,Re表示氫原子或可經氟原子取代之甲基: The liquid crystal alignment film according to item 1 of the scope of patent application, wherein the diamine component (a2) comprises a diamine compound (a2-1) represented by the formula (2): In formula (2), R a represents -CH 2- , -O-, -NH-, -N (CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -COO-, -OCO -, -CON (CH 3 )-or -N (CH 3 ) CO-; R b represents an unsubstituted or fluorine-substituted linear alkylene group having a carbon number of 1 to 20, and the alkylene group Any -CH 2 -in the group may be substituted by -CF 2- , -CH = CH-, or the following substituents, which include: -O-, -COO-, -NHCO-, -NH-, Carbocyclyl or heterocyclyl, wherein when two or more -CH 2 -are substituted with the substituent, the substituents are not adjacent; R c represents -CH 2- , -O-, -NH -, -N (CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -COO-, -OCO-, -CON (CH 3 )-, -N (CH 3 ) CO-, carbon A cyclic group or a heterocyclic group; Rd represents a vinyl phenyl group, -CR e = CH 2 , a carbocyclyl group, a heterocyclic group, or a group represented by the following structural formula, and R e represents a hydrogen atom or a fluorine atom Substituted methyl: . 如申請專利範圍第1項所述的液晶配向膜,其中所述二胺組份(a2)更包含由式(3)表示的二胺化合物(a2-2):式(3)中,R3表示-O-、,或者;R4表示含甾基團、碳數為2至30的伸烷基或由式(3-1)表示的有機基團:式(3-1)中,R5表示氫原子、氟原子或甲基;R6、R7或R8各自獨立表示單鍵、-O-、或碳數為1至3的伸烷基;R9表示,其中,R11及R12各自獨立表示氫原子、氟原子或甲基;R10表示氫原子、氟原子、碳數為1至12的烷基、碳數為1至12的氟烷基、碳數為1至12的烷氧基、-OCH2F、-OCHF2或-OCF3;a表示1或2;b、c及d各自獨立表示0至4的整數;e、f及g各自獨立表示0至3的整數,且e+f+g≧1;h及i各自獨立表示1或2;當存在多個R5、R6、R7、R8、R9、R10、R11或R12的情況下,多個R5、R6、R7、R8、R9、R10、R11或R12各自為相同或不同。The liquid crystal alignment film according to item 1 of the scope of patent application, wherein the diamine component (a2) further comprises a diamine compound (a2-2) represented by the formula (3): In formula (3), R 3 represents -O-, , , , ,or ; R 4 represents a steroid-containing group, an alkylene group having 2 to 30 carbon atoms, or an organic group represented by the formula (3-1): In the formula (3-1), R 5 represents a hydrogen atom, a fluorine atom or a methyl group; R 6 , R 7 or R 8 each independently represents a single bond, -O-, , , , , Or an alkylene group having 1 to 3 carbon atoms; R 9 represents or Wherein R 11 and R 12 each independently represent a hydrogen atom, a fluorine atom or a methyl group; R 10 represents a hydrogen atom, a fluorine atom, an alkyl group having 1 to 12 carbon atoms, a fluoroalkyl group having 1 to 12 carbon atoms, Alkoxy, -OCH 2 F, -OCHF 2 or -OCF 3 having a carbon number of 1 to 12; a represents 1 or 2; b, c, and d each independently represent an integer of 0 to 4; e, f, and g each Independently represents an integer from 0 to 3, and e + f + g ≧ 1; h and i each independently represent 1 or 2; when there are multiple R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R In the case of 11 or R 12 , a plurality of R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 or R 12 are each the same or different. 如申請專利範圍第3項所述的液晶配向膜,其中,基於所述二胺組份(a2)為100莫耳,所述二胺化合物(a2-1)的使用量為5莫耳至70莫耳。The liquid crystal alignment film according to item 3 of the scope of patent application, wherein based on the diamine component (a2) being 100 moles, the amount of the diamine compound (a2-1) used is 5 moles to 70 Mor. 如申請專利範圍第4項所述的液晶配向膜,其中,基於所述二胺組份(a2)為100莫耳,所述二胺化合物(a2-2)的使用量為3莫耳至50莫耳。The liquid crystal alignment film according to item 4 of the scope of patent application, wherein based on the diamine component (a2) being 100 moles, the amount of the diamine compound (a2-2) used is 3 moles to 50 Mor. 一種液晶顯示元件,其包括如申請專利範圍第1項至第6項中任一項所述的液晶配向膜。A liquid crystal display element includes the liquid crystal alignment film according to any one of claims 1 to 6 of a patent application scope. 一種液晶顯示元件的製造方法,包括:分別於包含導電膜的一對基板上形成如申請專利範圍第1項至第6項中任一項所述的液晶配向膜;將形成有所述液晶配向膜的所述基板以所述液晶配向膜對向的方式配置;於所述基板之間注入液晶組成物而形成液晶胞;以及於所述導電膜間施加電壓,並於施加電壓狀態下用光照射所述液晶胞。A method for manufacturing a liquid crystal display element includes: forming a liquid crystal alignment film according to any one of claims 1 to 6 on a pair of substrates including a conductive film; and forming the liquid crystal alignment. The substrate of the film is arranged in such a manner that the liquid crystal alignment film is opposite to each other; a liquid crystal composition is injected between the substrates to form a liquid crystal cell; and a voltage is applied between the conductive films, and the light is used in the state of the applied voltage. The liquid crystal cell is irradiated.
TW104137827A 2015-11-17 2015-11-17 Liquid crystal alignment film, liquid crystal display element and manufacturing method of the same TWI632177B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW104137827A TWI632177B (en) 2015-11-17 2015-11-17 Liquid crystal alignment film, liquid crystal display element and manufacturing method of the same
CN201610976074.8A CN106978195B (en) 2015-11-17 2016-11-07 Liquid crystal alignment film, liquid crystal display assembly and manufacturing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW104137827A TWI632177B (en) 2015-11-17 2015-11-17 Liquid crystal alignment film, liquid crystal display element and manufacturing method of the same

Publications (2)

Publication Number Publication Date
TW201718708A TW201718708A (en) 2017-06-01
TWI632177B true TWI632177B (en) 2018-08-11

Family

ID=59340442

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104137827A TWI632177B (en) 2015-11-17 2015-11-17 Liquid crystal alignment film, liquid crystal display element and manufacturing method of the same

Country Status (2)

Country Link
CN (1) CN106978195B (en)
TW (1) TWI632177B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112041739B (en) * 2018-04-27 2024-06-11 日产化学株式会社 Liquid crystal light modulation element

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200946565A (en) * 2008-05-09 2009-11-16 Chi Mei Corp Liquid crystal alignment agent and manufacturing method of liquid crystal alignment film made from the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL167462B1 (en) * 1991-07-26 1995-09-30 Wyzsza Szkola Inzynierska Method of producing polymeric layers for orientattion o liquid crystals
JPH08152617A (en) * 1994-11-29 1996-06-11 Toray Ind Inc Color filter
JP2003055456A (en) * 2001-07-25 2003-02-26 Ind Technol Res Inst Liquid crystal alignment film composition for liquid crystal display
US20130310572A1 (en) * 2008-03-18 2013-11-21 Chi Mei Corporation Liquid crystal alignment film and liquid crystal alignment element using the same
CN101576687B (en) * 2008-05-08 2011-07-20 奇美实业股份有限公司 Liquid crystal directing agent, and production method of liquid crystal oriented film formed by same
KR101688687B1 (en) * 2010-02-26 2016-12-21 닛산 가가쿠 고교 가부시키 가이샤 Liquid crystal aligning agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200946565A (en) * 2008-05-09 2009-11-16 Chi Mei Corp Liquid crystal alignment agent and manufacturing method of liquid crystal alignment film made from the same

Also Published As

Publication number Publication date
CN106978195A (en) 2017-07-25
TW201718708A (en) 2017-06-01
CN106978195B (en) 2020-12-01

Similar Documents

Publication Publication Date Title
CN104516151B (en) Method for producing liquid crystal alignment film, photo-alignment agent, and liquid crystal display element
KR101385331B1 (en) Liquid crystal display element and liquid crystal aligning agent
JP5527538B2 (en) Liquid crystal aligning agent, method for producing liquid crystal aligning film, and liquid crystal display element
TWI470030B (en) Liquid crystal alignment agent, liquid crystal display element, and method of manufacturing the same
JP5466872B2 (en) LIQUID CRYSTAL ALIGNANT, LIQUID CRYSTAL ALIGNMENT FILM FORMED FROM THE SAME, ITS MANUFACTURING METHOD, AND LIQUID CRYSTAL DISPLAY DEVICE PROVIDED WITH THE ALIGN
KR102411032B1 (en) Liquid crystal display element, liquid crystal alignment film, and liquid crystal alignment treatment agent
JP5556395B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element
JP2007225791A (en) Homeotropic alignment type liquid crystal aligning agent and homeotropic alignment type liquid crystal display element
JP2010066630A (en) Method for manufacturing optical film, and optical film
JP4978433B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5041169B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW201617408A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2015182894A1 (en) Photoreactive diamine monomer polymerization and lcd alignment film using same
KR101999240B1 (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display device, and manufacturing method for the liquid crystal alignment film
KR20140140476A (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display device, polymer and compound
KR101536008B1 (en) Liquid crystal aligning agent and liquid crystal display device
CN107880902B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly
CN106462011B (en) Liquid crystal display element, liquid crystal alignment film, and liquid crystal alignment treatment agent
KR101536007B1 (en) Liquid crystal aligning agent and liquid crystal display device
KR101397293B1 (en) Liquid crystal aligning agent and liquid crystal display device
TWI632177B (en) Liquid crystal alignment film, liquid crystal display element and manufacturing method of the same
CN107043630B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly
KR101588904B1 (en) Liquid crystal aligning agent and liquid crystal display device
TW201617407A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR101042059B1 (en) Liquid crystal aligning agent and liquid crystal display device

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees